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CHAPTER ONE 
LITERATURE REVIEW 
Introduction 
 Polysaccharides are polymers made from sugar subunits arranged together in the form of 
a linear or branched chain. These polymers can range in length from only a few subunits to 
around 10,000 subunits in the case of some cellulose fibers. Polysaccharides are ubiquitous in 
nature and can be utilized by cells as nutrient sources [1], as structural polymers [2], as signaling 
polymers [3], and in industrial and clinical settings[4, 5]. 
 The production of polysaccharides is carried out by a class of enzymes known as 
glycosyltransferases (GTs). GTs facilitate the formation of long and short chain polysaccharides 
by catalyzing glycosidic bond formation between sugar subunits. These enzymes are found in all 
domains of life and are necessary for a variety of functions. One of these functions in bacteria is 
the production of exopolysaccharide for biofilm. Bacterial biofilms are colonies of organisms 
that are encased in a sticky substance and often attached to a surface.  
 Vibrio fischeri is a marine bacterium that utilizes biofilm formation as a means to 
colonize its natural host, the Euprymna scolopes squid [6]. The 18 gene syp locus encodes the 
proteins that produce the exopolysaccharide component of the biofilm [7, 8]. Without this 
polysaccharide, biofilm cannot form and the bacteria cannot colonize the squid. Of the 18 genes 
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in the locus, 6 are predicted to encode glycosyltransferases. The goal of my thesis was to probe 
the structure and function of one of these GTs: SypQ. This enzyme functions in an unknown 
mechanism to control biofilm formation in Vibrio fischeri. To better understand the activity of 
SypQ, I used genetic approaches to identify amino acid residues important for its function. Here, 
I provide an overview of glycosyltransferases: in particular family 2 glycosyltransferases, the 
class of glycosyltransferase that includes SypQ. I also discuss exopolysaccharide biosynthesis 
pathways. Finally, I discuss biofilms, in particular V. fischeri biofilms and the exopolysaccharide 
contribution to these biofilms. 
Glycosyltransferases 
 Glycosyltransferases (GTs) are enzymes responsible for catalyzing the formation of 
glycosidic bonds using an activated sugar as a substrate. GTs are found in all domains of life. 
The number of glycosyltransferases that an organism encodes directly correlates to the number 
genes present. Approximately 1-2% of the genes in an organism encode glycosyltransferases  
[9].  
Classification. 
 There are currently over seven thousand sequenced glycosyltransferases. These enzymes 
are classified into several families (currently, more than 80) based on a number of factors. One 
level of classification is based on overall amino acid sequence [10]. Members of a GT family 
will often contain conserved functional motifs in their amino acid sequence. For example, the 
family 2 glycosyltransferases (GT-2s) contain a highly conserved DxD motif that has been 
shown to function in the active site to facilitate substrate binding and coordination of divalent 
cations that are essential for the enzyme’s function.   
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Another level of classification is the catalytic mechanism of the enzyme. 
Glycosyltransferases catalyze the formation of a glycosidic bond between the sugar substrate and 
the receiving molecule or growing polysaccharide chain. The catalysis will result in one of two 
possible outcomes: the stereochemistry of the donor molecule will be retained or it will be 
inverted (Figure 1A).  
The final level of classification is the three-dimensional fold of the protein. Nearly all of 
the GT structures that have been solved to date either have a GT-A fold or a GT-B fold (Figure 
1B) [9]. Both folds are similar in that they are composed of two β/α/β Rossman-like folds. The 
GT-A and GT-B folds differ in how they contribute to the overall structure and catalytic activity 
of the protein. In the GT-A fold, the β-sheets of the two Rossman-like folds come in close 
contact with one another and create a continuous domain of β-sheets in the center of the enzyme. 
This large β-sheet contains the active site. The GT-B fold, on the other hand, adopts a different 
conformation. The two Rossman folds face each other, forming a cleft between them. The active 
site is located within this cleft region.  These individual classifications combine to categorize a 
GT into a family. Despite the large number of known GT families, family 2 (which have a GT-A 
fold) and family 4 (which have a GT-B fold) are the most common families of GTs. 
Approximately 50% of all GTs belong to one of these two families [9]. 
12 
 
 
 
 
  
Figure 1. Structure and mechanisms of glycosyltransferases. A. Glycosyltransferases will catalyze the formation 
of glycosidic bonds via an inverting mechanism, in which the orientation of the anomeric carbon changes, or a 
retaining mechanism, where the anomeric carbon retains its orientation. B. Glycosyltransferases adopt one of two 
structural folds: a GT-A fold or a GT-B fold. Both folds are composed of two β/α/β folds. In the GT-A structure, the 
two folds come together to form a continuous β sheet at the base while in the GT-B structure, the two folds face 
each other and form a cleft between them [9].  Reprinted with permissions (Appendix B). 
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Family 2 glycosyltransferases. 
 The class of family 2 glycosyltransferases (GT-2s), which is one of the largest GT 
families, contains enzymes from all domains of life. While not all GT-2s are identical in 
sequence or in their substrate and product, they do all possess the same basic properties. All the 
known GT-2 enzymes adopt a similar 3-dimensional structure. While the size of the protein and 
number of transmembrane regions may differ, all GT-2s have a GT-A fold architecture. This 
similarity in structure leads to a similar mechanism of action as well. All members of this family 
of GTs catalyze the formation of glycosidic bonds via an inverting mechanism. In addition to 
structure and mechanism, GT-2s share some sequence similarities within the active region of the 
enzyme through the conservation of multiple functional motifs. This motif conservation is well 
characterized in one class of GT-2 enzyme in particular: the cellulose synthase catalytic subunit 
A (CesA) [11]. CesA and CesA-like enzymes have been thoroughly investigated in both plants 
(CesA) and in bacteria (BcsA). These enzymes catalyze the formation of the α(1-4) glycosidic 
bond between the donor sugar (a nucleotide diphosphate glucose) and the non-reducing end of 
the growing cellulose chain. 
  The catalytic domain of CesA enzymes consists of three variably spaced aspartic acids 
found within specific motifs in the primary amino acid sequence [12]. These conserved residues 
are flanked downstream by another motif, the Q/LxxRW motif (Figure 2). Together, these 
residues create the larger D, D, D, Q/LxxRW motif. The three aspartic acids are in the DDx, 
DxD, and TED motifs respectively [11, 12]. The number of amino acids that separates these 
motifs differs from enzyme to enzyme. Despite this variability, the functional motifs are often 
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arranged in the same location in the three-dimensional structure and the arrangement of these 
motifs is often conserved among CesA proteins from plants as well as bacteria [13, 14]. 
 
Figure 2. Alignment of GT-2s demonstrating conservation of the D, D, D, Q/LxxRW motif. As demonstrated 
by Saxena et. al., 1995, GT-2s share a specific conservation of certain motifs. Sequences from four processive GTs 
were aligned and the conserved residues indicated by an asterisk. The residues in bold type are those conserved in 
the functional motifs: DDx, DxD, TED, and Q/LxxRW, respectively [12]. 
  
BcsA. Many bacteria encode a CesA protein called BcsA (bacterial cellulose synthase). 
This protein has been well characterized in its mechanism as well as its structure [13, 15]. The 
BcsA sequence contains the motifs known to contribute to catalytic function. The first 
catalytically active aspartate in BcsA is the secondary aspartic acid in the DDx motif. The DDx 
motif is located adjacent to the DxD motif in the active site of the three-dimensional structure 
and the central aspartic acid interacts with the nucleotide bound to the donor sugar [16]. In other 
15 
 
 
 
GT-2 enzymes, the DDx motif has been indicated in bifunctionality within a single active site or 
the ability of the enzyme to catalyze the formation of both α- and β-glycosidic bonds [17].  
The second essential aspartic acid is found in the DxD motif (in some GT-2s, the DxD is 
substituted with a DxH [18]). The role of the DxD functional motif has been well characterized 
in BcsA. These residues function in the active site where they interact with the phosphate of the 
nucleotide donor molecule and coordinate the divalent cations needed for the function of BcsA 
[11, 19, 20]. These cations stabilize the leaving group after the catalysis of the glycosidic bond. It 
has also been observed that the primary aspartic acid of this motif is flanked upstream by four 
hydrophobic residues [13, 21]. 
The third conserved aspartic acid residue in the BcsA catalytic active site is the terminal 
aspartate of the TED motif. This amino acid interacts with the acceptor molecule of the growing 
polysaccharide chain through hydrogen bonding. The aspartic acid then catalyzes the 
deprotonation of the growing chain at the non-reducing end [11, 20]. This allows the hydroxyl 
group of the donor molecule to bind to the growing polysaccharide chain.  
While the conserved aspartic acid residues are involved in the catalytic activities of the 
BcsA active site, the Q/LxxRW motif is important for stabilizing the growing chain [14]. In 
BcsA, the tryptophan residue forms part of the transmembrane channel entrance.  From here, the 
tryptophan interacts with the growing chain to keep the nonreducing end in proper position to 
interact with the aspartic acid residue from the TED motif. Keeping the two residues close to 
each other is essential for glycosidic bond formation [11].  
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Bacterial Exopolysaccharides 
Functional Roles. 
Bacterial exopolysaccharides (EPS) serve many functions. EPS that are bound to the cell 
contribute to capsule formation, which can protect the cells from desiccation and act as receptors 
for the cells [1]. Polysaccharides that are secreted into the extracellular space most often become 
the major component of the bacterial biofilm matrix. Within the matrix, the EPS polymers can 
have several functions. The polysaccharides facilitate adhesion of the cells to a surface, allowing 
for the initial stages of biofilm development. The EPS in biofilms can protect the bacteria from 
immune defenses during an infection (e.g. [22]) as well as confer resistance to antibiotic 
treatment (e.g. [23]). Thus, understanding how EPS is produced can lead to the development of 
effective treatment options. 
Mechanisms of Production.  
Despite the vast diversity of bacterial EPS, there are currently only four known 
mechanisms of production. The two most common pathways to EPS production are the 
Wzx/Wzy-dependent pathway and the ABC transporter-dependent pathway. Bacterial cells can 
also utilize the synthase-dependent pathway or produce the polysaccharide extracellularly 
through the use of a glycosyltransferase covalently bound to the cell surface [22]. 
 Wzx/Wzy-dependent pathway. All polysaccharides made by the Wxz/Wxy-dependent 
pathway are heteropolymers, meaning that they are composed of multiple distinct sugar subunits. 
This makes the resulting polysaccharides incredibly diverse. This mechanism of EPS production 
is so named because all bacterial strains utilizing this method possess Wzx- and Wzy-like 
proteins. To begin the process, glycosyltransferases at the inner membrane generate individual 
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sugars. The proteins required for the polymerization of the polysaccharide chain are complexed 
at the inner membrane. There are three major players in the complex: Wzx, Wzy, and Wzz [24]. 
The Wzx protein is a flippase responsible for transferring the individual sugars to the periplasm, 
where they are polymerized into a chain by the Wzy protein. The length of the polysaccharide 
chain is controlled by the Wzz protein. These proteins have the capacity to oligomerize and, in 
the case of Wzz, this oligomerization contributes directly to its function [25]. If the 
polysaccharide is designated for capsule formation, the WaaL ligase protein will ligate the 
polysaccharide to a lipid oligosaccharide to form lipopolysaccharide. Once the polysaccharide 
chain is formed, two more proteins are needed to export the polymer out of the cell: a 
polysaccharide co-polymerase (PCP) and an outer membrane polysaccharide export (OPX) 
protein. 
 ATP binding cassette (ABC) transporter dependent pathway.  The ATP-binding 
cassette transporter-dependent pathway is used primarily for the production of capsular 
polysaccharide. It is similar to the Wzx/Wzy-dependent pathway in that the process begins with 
the production of individual sugars at the inner membrane by membrane integrated 
glycosyltransferases. Unlike the Wzx/Wzy pathway, the sugar molecules are transported to the 
periplasm by a pump-like complex rather than a flippase. This complex is composed of 
transporter proteins and proteins from the PCP and OPX families. One major difference in the 
ABC transporter system, however, is that the entire polysaccharide chain is produced in the 
cytoplasm and is then transported to the pump complex by the ABC transporter complex [22].  
 Synthase-dependent pathway. There are noticeable differences in the synthase-
dependent pathway compared to the Wzx/Wzy and ABC transporter pathways. The synthase-
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dependent pathway produces homopolymers [26]. The polysaccharides produced in this pathway 
contain one kind of sugar molecule. Some examples of the polymers generated are curdlin, 
alginate, and hyaluronic acid. Another difference is that the polymerization and translocation 
occur simultaneously. A glycosyltransferase embedded in the inner membrane catalyzes the 
formation of the polysaccharide and exports it at the same time [22]. The regulation of 
polysaccharide production is often achieved by a co-polymerase [27]. This co-polymerase 
contains a PilZ domain and regulates the production of polysaccharide through c-di-GMP 
binding. The polysaccharide is stabilized in the periplasm by a scaffold protein and exported 
through a β-barrel porin protein. These export proteins are clearly distinct from the PCP and 
OPX protein common to the Wzx/Wzy and ABC transporter mechanisms. 
 Extracellular synthase pathway. Not all bacterial EPS is generated by a complex of 
proteins and not all exopolysaccharides are produced intracellularly. In the extracellular synthase 
pathway, the exopolysaccharide is produced by a glycosyltransferase that is covalently linked to 
the cell surface. Two examples of polysaccharide generated by this pathway are dextran and 
levan [28, 29]. 
Biofilm 
 Exopolysaccharides are the primary component of the bacterial biofilm matrix. Bacterial 
biofilms are sessile social communities that form on organic or inorganic surfaces and surround 
themselves with a thick sticky substance [30, 31]. This substance is composed primarily of 
exopolysaccharide, extracellular protein, and extracellular DNA. Biofilms and their communities 
are very diverse depending on the species (single species or multi-species) that make up the 
community and the environment in which the biofilm is formed [32]. Despite this heterogeneity, 
19 
 
 
 
bacterial biofilms possess some basic similar characteristics in their formation, matrices, and 
function. These similar characteristics will be described below. 
Stages of Bacterial Biofilm Formation. 
 Environmental factors can induce bacterial biofilm formation. Environmental changes 
can lead bacteria to initiate biofilm formation by changing from a planktonic lifestyle to a sessile 
one [33]. The first stage of biofilm formation occurs when the planktonic cells attach to a 
surface. Extracellular appendages that aid in motility, such as flagella, enhance the bacteria’s 
attachment to a surface [34].   
Once the bacteria have attached to a surface, the transition to a sessile lifestyle is 
triggered by the upregulation of factors needed for the formation of the biofilm matrix [35, 36], 
beginning the process of biofilm maturation. The biofilm matrix accounts for approximately 90% 
of the biomass of the colony [37] and can enhance bacterial survival by trapping nutrients and 
water. Bacteria can adjust the matrix to suit changes in environment by secreting enzymes that 
alter the EPS component. 
The final stage in bacterial biofilm development is the dispersal stage. Dispersal from the 
biofilm can be either active or passive. Passive dispersal occurs by physical disruption of the 
colony but can also occur in response to external stimuli such as a change in nutrient levels [38]. 
It has also been demonstrated that iron levels can trigger the dispersal of planktonic bacteria 
from mature biofilms [39]. 
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Biofilm Matrix. 
 The matrix of bacterial biofilms accounts for the majority of the biomass [37]. The 
individual components of biofilm matrices can differ from biofilm to biofilm; however, the 
majority of bacterial biofilm matrices contain extracellular polysaccharides [(exopolysaccharides 
(EPS)], proteins, and DNA (eDNA).  
 The EPS is a key component of the biofilm matrix [32]. For example, in V. cholerae, 
50% of the biomass of the biofilm is composed of the VPS polysaccharide [40-42]. Biofilm EPS 
is not always composed of a singular polymer. Often, the EPS is made of multiple different 
polysaccharides whose production can be regulated by separate pathways. The matrix EPS can 
interact with other components in the biofilm. Carbohydrate binding proteins can bind to EPS 
and form cross-links that can strengthen the matrix [37, 43]. Extracellular DNA (eDNA) is 
another integral part of the matrix and can also interact with the EPS. In P. aeruginosa, the 
eDNA interacts with the PSL polysaccharide to create a structure that supports to the biofilm 
[44].  
 The matrix has many functions in biofilms. Nutrients and water can become trapped in 
the matrix, which then supplies these much needed elements to the cellular community [45]. 
Cells within the matrix are held in close proximity via the cross-links formed by EPS and 
proteins [37]. This closeness allows for intercellular interactions and signaling. The matrix can 
also act like a recycling center. When cells die in the matrix, their components are kept close and 
the neighboring cells can utilize them.    
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Functional Roles of Biofilms. 
 Bacterial biofilms confer a number of benefits to the microbial communities that live 
within them. One major benefit to the bacterial cells is protection. Studies have demonstrated 
that the biofilm produced by P. aeruginosa can protect the cells within from antibiotics [23]. A 
recent study of V. cholerae biofilms demonstrated that the cells within the matrix were protected 
from invading bacterial cells [46]: motile V. cholerae cells could colonize the outside of the 
established biofilm but could not enter the matrix.  
Clinical and Industrial Significance of Biofilms. 
 Approximately 80% of all human bacterial infections involve the formation of biofilm in 
some way. In a clinical setting, biofilm-associated infections are commonly seen with implanted 
devices such as catheters, artificial joint replacements, and implanted devices such as 
pacemakers [47, 48]. The biofilm-associated infections can lead to the ability of antibiotic 
resistant cells to persist in the body, which in turn can lead to chronic infection. In addition to 
creating problems in a clinical setting, bacterial biofilms have been shown to have a negative 
effect on industry, in particular the food industry where they can lead to food spoilage, 
contamination, and disease [49].  
Vibrio fischeri 
Symbiosis. 
 Vibrio fischeri is the natural symbiont of Euprymna scolopes, the Hawaiian bobtail squid. 
The V. fischeri bacteria produce light that allows the squid to evade predators [50]. The 
specificity of the symbiosis is such that, of the multitude of bacterial species in marine 
environments, only V. fischeri is capable of colonizing the light organ of the E. scolopes squid 
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[51]. Despite this specificity, V. fischeri  must overcome many obstacles to achieve colonization, 
such as removal by phagocytes and reactive oxygen species [50]. V. fischeri biofilm allows the 
bacteria to attach to the surface at the opening to the light organ and colonize the squid. 
The Contribution of syp Genes to V. fischeri Biofilm. 
 Previous genetic studies of V. fischeri have identified an 18-gene locus essential to the 
promotion of biofilm formation and symbiotic colonization [52]. This locus, the symbiotic 
polysaccharide (syp) locus, has been shown to contribute to the production and secretion of the 
exopolysaccharide component of the biofilm matrix [7]. All of the structural proteins encoded in 
the locus are important for colonization.  Of the 18 genes in the locus, there are four that encode 
putative regulatory proteins, sypA, E, F, and G, and two that encode putative polysaccharide 
export proteins, sypC and sypK. Six genes, sypB, D, L, M, O and R, are thought to encode 
proteins that modify the syp polysaccharide or control the length of the growing polymer and the 
remaining genes, sypH, I, J, N, P, and Q, encode putative glycosyltransferases [8, 53]. A 
disruption to any one of these genes results in a reduction or total abrogation of biofilm 
formation in vitro as well as a reduction or loss of colonization of the E. scolopes by V. fischeri.  
 syp transcription is controlled through a network of regulatory proteins. The sensor 
kinase RscS is activated upon reception of an as of yet unknown signal [54, 55]. Once activated, 
RscS will activate the response regulator SypG. SypG is an essential transcriptional regulator 
that binds to the syp promotor regions to initiate σ54 transcription [56]. RscS also controls the 
activity of the response regulator SypE [57]. SypE has both positive and negative regulatory 
capabilities and regulates syp activation by controlling the activity of SypA, whose function is 
still unknown [58]. In vitro, biofilm formation can be induced in V. fischeri through the 
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overexpression of RscS. This overexpression induces the positive regulatory function of SypE by 
activating its C-terminal domain [57]. Biofilm can also be induced by overexpression of SypG in 
the absence of SypE [59]. Under the inducing conditions, V. fischeri forms wrinkled colonies 
(instead of smooth) and pellicles (biofilms at the air/liquid interface of static cultures).  
 Of the 6 putative syp glycosyltransferases, one is of particular interest: SypQ. While 
sypH, I, J, N, and P encode putative GT-1 family glycosyltransferases, only sypQ encodes a 
putative GT-2 enzyme. The deletion of sypQ results in a total loss of biofilm as well as a light 
colony phenotype (Thomson and Visick unpublished data) that mimics that of mutations in the 
regulatory genes. Understanding SypQ and its role in the production of the V. fischeri syp 
polysaccharide is an essential step in understanding the mechanism by which this polysaccharide 
is made.  
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CHAPTER TWO 
MATERIALS AND METHODS 
 
Strains and Media 
All bacterial strains utilized in this study are listed in Table 1. V. fischeri strains were 
derived via triparental conjugation into recipient V. fischeri strains KV5562 or KV4883. GT115 
(Invivogen, San Diego, CA), and TAM1 competent E. coli cells were used for conjugation and 
cloning [6]. E. coli strain CC130, a derivative of the  Mph44 [60] mutator strain, was used for 
random mutagenesis of sypQ. All V. fischeri strains were grown using Luria-Bertani salt (LBS) 
medium [61]. The following antibiotics were added to the LBS medium: Chloramphenicol (Cm) 
at a final concentration of 2.5 μg/ml, and/or Tetracycline (Tet) at a final concentration of 2.5 
μg/ml. E. coli strains were grown in Luria-Bertani medium (LB). Ampicillin (Amp) at a final 
concentration of 100 μg/ml and Cm at a final concentration of 12.5 μg/ml were added to the LB 
media. Thymidine was added when appropriate at a final concentration of 0.003 M. 
Transformation 
Bacterial transformation was used to introduce plasmid DNA into E. coli strains. 5 µl of 
plasmid DNA was added to 50 µl of competent cells. The mixture was incubated on ice for 30 
minutes. The cells were heat shocked at 42°C for exactly 30 seconds then rested on ice for 2 
minutes. Cells were then incubated in Super Optimal Broth with catabolite repression (SOC) [62] 
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at 37°C for 1 hour. 100 μl of the cell culture was plated on LB plates containing Amp or Cm and 
incubated at 37°C overnight. 
To make E. coli cells competent, cells were first incubated overnight in 5 ml of LB media 
at 37°C with shaking at 220 rpm. After incubation, 2.5 ml of the overnight culture was used to 
inoculate 250 ml of fresh LB. The cells were grown at 37°C to an optical density at 600 nm 
(OD600) of 0.3. The culture was incubated on ice for 15 to 20 minutes. The cells were centrifuged 
at 2000xg for 15 minutes at 4°C. The cells were resuspended in 100 ml of 100mM CaCl2 and 
incubated on ice for 20 minutes. The suspension was centrifuged for 15 minutes at 2000xg at 
4°C. The pellet was resuspended in 100 ml of 100mM CaCl2 and incubated on ice overnight at 
4°C. After incubation, glycerol was added to a final concentration of 10% and the cells were 
aliquoted and frozen at -80°C   
Conjugation 
Triparental conjugation was used to introduce plasmid DNA into V. fischeri strains. E. 
coli strains containing the sypQ plasmid DNA and the helper E. coli strain pEVS104 [63] were 
grown overnight in LB broth containing the appropriate antibiotic at 37°C with shaking at 220 
rpm. The recipient V. fischeri strain was grown overnight in LBS plus Tet at 28°C with shaking 
at 220 rpm. After incubation, a 50 µl aliquot of each overnight culture was diluted in 5 ml of 
liquid medium plus antibiotic and incubated at the appropriate temperature with shaking for ~2 
hours. Post incubation, 250 µl of the donor E. coli strain, 250 µl of the pEVS104 helper E. coli 
strain, and 1 ml of the recipient V. fischeri strain were combined in a 1.5 ml Eppendorf tube and 
centrifuged at 13,000 rpm for 2 minutes. The supernatant was discarded and the pellet was 
resuspended in 10 µl of the remaining liquid. The cellular suspension was then spotted onto an 
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LBS plate and incubated at 28°C for a minimum of 3 hours but no longer than overnight. The 
spot was resuspended in 1 ml of LBS and 100 µl of the suspension was plated onto LBS plates 
containing Cm and Tet. For the random mutagenesis, the resuspended spot was diluted before 
plating. 2 µl of the suspension was added to 1 ml of LBS (a 1:500 dilution). The plates were 
incubated at 24°C for 48 hours. To isolate V. fischeri from the E. coli background, the V. fischeri 
colonies were streaked onto a fresh plate. 
PCR Reactions 
Primers used in this study are listed in Table 2. sypQ alleles containing either a FLAG 
epitope tag (pCKM1-4) or a single site-directed point mutation (pMKF2-13), were generated 
using a PCR SOEing (splicing by overlap extension) reaction [64]. Primers containing either the 
FLAG epitope tag or the specific point mutation were used to generate tagged/mutated fragments 
of sypQ with overlapping ends. 5 µl of 10X KOD polymerase buffer, 3 µl of 25 mM MgCl2, 5 µl 
of 2 mM dNTPs, 1 µl each of the 20 µM required forward and reverse primers, 1 µl of the DNA 
template, and 0.4 µl of the KOD HiFi polymerase were added to 33.6 µl of dH2O. The reaction 
was processed using a BioRad MJ mini personal thermo cycler or a T100 thermo cycler using the 
following parameters: a denaturing step at 98°C for 15 seconds, an annealing step at 55°C for 5 
seconds, and an extension step at 72°C for 15 seconds. The cycles were repeated thirty times. 
The product was then cleaned and concentrated using the Zymogen (Irvine, CA.) Clean and 
Concentrate kit. The resulting fragments were annealed together without primers at the 
overlapping regions and the strand was extended with the overlap acting as the free 3’ end. 5 µl 
of 10X KOD polymerase buffer, 3 µl of 25 mM MgCl2, 5 µl of 2mM dNTPs, approximately 100 
ng of each of the fragments from the previous PCR reaction, and 0.4 µl of the KOD HiFi 
27 
 
 
 
polymerase were added to dH2O for a final volume of 50 µl. The reaction was completed using 
the previously stated parameters. The cycles were repeated twenty times. This mega-fragment 
was then amplified using primers 1963 and 1964. The reaction was completed using the previous 
parameters and running for thirty cycles. The amplified sypQ allele was then ligated into the 
pJET 1.2 blunt cloning vector (Thermo Scientific, Waltham, MA.) (see below).  
The pMKF1 plasmid was generated by first amplifying the syp promoter from ES114 
chromosomal DNA via a traditional PCR reaction [65]. Primers were used to first amplify the 
syp promotor. 0.5 µl of ES114 chromosomal DNA, 5 µl of 5X reaction buffer (Promega, 
Madison, WI.), 2 µl of 2.5 mM dNTPs, 1.5 µl of 25 mM MgCl2¸1.5 µl of 20 µM forward primer 
(1991) and 1.5 µl of 20 µM of reverse primer (1992) were added to 12.875 µl of dH2O and 0.125 
µl of Taq polymerase (Promega). The reaction was completed using a BioRad MJ mini personal 
thermo cycler or a T100 thermo cycler with the following parameters: an initial denaturing step 
at 95°C or 2 minutes, a cycle denaturing step at 95°C for 1 minute, an annealing step at 55°C for 
30 seconds, and an extension step at 72°C for 1.5 minutes. The cycle (steps 2-4) was repeated 30 
times. Following the final cycle, a final extension step was performed at 72°C for 5 minutes. The 
final product was stored at 4°C until needed. The amplified syp promotor was ligated into the 
pJET cloning vector and transformed into TAM1 competent E. coli.  
Digests and Ligations 
Plasmids used in this study are listed in Table 3. For cloning of the site-directed sypQ 
mutants, 5 µl of the 2X pJET reaction buffer, 3.5 µl of dH2O, 0.5 µl of the amplified PCR 
product, and 0.5 µl of the pJET blunt cloning vector were incubated with 0.5 µl of T4 DNA 
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ligase at room temperature for 5 minutes and then transformed into TAM1 competent E. coli 
cells. The cells were then plated on LB media with Amp and incubated at 37°C overnight. 
DNA digestions were used to excise the target gene from the pJET cloning vector and to 
verify the presence of the insert in the pMKF1 plasmid backbone. 1 µL of 10X digest buffer 
(Thermo Fischer Scientific), 0.5 µl of the required fast digest restriction enzymes (SacI, SalI, and 
BglII) (Thermo Fischer Scientific), and 5 µl of plasmid DNA were added to dH2O to a final 
volume of 10 µl. The mixture was incubated at 37°C for 30 minutes. The digestion product was 
resolved on a 1% agarose gel at 110V for 35-45 minutes. For cloning of the sypQ insert into the 
pMKF1 plasmid, the sypQ band was excised from the gel and the DNA was recovered using the 
Zymogen Gel DNA recovery kit. The extracted DNA was then ligated into the pMKF1 
backbone. 3 µl of the digested pMKF1 backbone and 1 µl of the digested insert (a vector to 
insert ratio of 3:1) were incubated with 4.5 µl of dH2O, 1 µl of 10X T4 ligation buffer, and 0.5 µl 
of T4 DNA ligase at room temperature overnight. The ligation product was then transformed into 
GT115 competent E. coli cells. To verify the presence of the insert, the plasmid was extracted 
using the Zymogen Plasmid Miniprep kit and sequenced using ACGT Inc. (Wheeling, IL).  
Bioinformatics 
Multiple sequence alignments were performed using the Clustal W server [66, 67]. To 
perform sequence analysis on the mutated sypQ alleles, an NCBI BLAST analysis was 
performed [68]. To predict potential transmembrane regions of SypQ, the sequence was entered 
into both the PredictProtein [69] and Topcons [70] bioinformatic servers. The Phyre2 [71] sever 
was utilized to predict a possible structure for SypQ. 
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Site-directed Mutagenesis of sypQ 
Mutants of sypQ containing specific point mutations were generated using a PCR SOEing 
reaction. The mutated allele of sypQ was ligated into the pMKF1 backbone and transformed into 
GT115 competent E. coli cells. The plasmid was introduced into V. fischeri strain KV5562 and 
KV4883 via triparental conjugation. A wrinkled colony assay was performed to determine if the 
sypQ allele containing the specific point mutation was capable of restoring biofilm formation to a 
sypQ deficient strain of V. fischeri. 
Random Mutagenesis of sypQ 
To introduce random mutations in sypQ, the pMKF1 plasmid was grown in the CC130 
mutator E. coli strain. The plasmid was introduced into the cells via transformation as previously 
described. The mutated plasmid was then introduced into the KV5562 V. fischeri strain via 
triparental conjugation. The conjugation spot was incubated at 28°C for three hours. For each 
independent mutagenesis, the conjugation spot was resuspended in 1 ml of LBS broth and 
diluted by adding 2 µl of the suspension to 1 ml of LBS. 100 µl of the dilution was plated onto 
each of 7 LBS plates containing Cm and Tet (at final concentrations of 2.5 µg/ml for each 
antibiotic). The plates were incubated at 24°C for 5 days (~220 hours). After 72 hours, the plates 
were counted to determine the number of colonies/plate. After 220 hours, the plates were 
screened for any colonies with a mutated phenotype (smooth, delayed, dark, or architecturally 
abnormal). These isolates were streaked onto LBS plates containing Cm and Tet and incubated at 
24°C for 48 hours. The isolates were restreaked to generate single colonies. A wrinkled colony 
assay (see below) was performed to determine whether the randomly mutated sypQ allele was 
capable of restoring biofilm to the sypQ deficient strain. To determine if the observed mutant 
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phenotype was due to a mutation in the sypQ allele on the plasmid, the plasmid was extracted 
using the quick boil method and transformed into GT115 competent E. coli cells. The plasmid 
was then introduced back in to the parent strain (KV5562) via triparental conjugation.  A 
wrinkled colony assay was performed to determine if the original defective phenotype was 
retained, a result that would suggest that the sypQ allele on the plasmid carried a mutation. Any 
plasmid that resulted in a delayed or diminished phenotype was extracted from the corresponding 
GT115 cells using a Zymogen Plasmid Miniprep kit. The concentration of the extracted plasmid 
was determined using a nanodrop. Mutations were identified by sequence analysis with primers 
M13R and M13F-20 using ACGT Inc. (Wheeling, IL). For sypQ alleles that resulted in a smooth 
colony phenotype, the corresponding plasmids were transferred into KV4883 (see below). 
Wrinkled Colony Formation Assay 
To assess the ability of the mutant sypQ alleles to restore biofilm formation to a sypQ 
deficient strain of V. fischeri (KV5562), V. fischeri strains containing the plasmids carrying the 
mutated sypQ allele were streaked onto LBS plates containing the appropriate antibiotic. Single 
colonies were collected and grown overnight in liquid LBS media with appropriate antibiotics 
and shaking at 220 rpm. In later experiments, the cultures were standardized to an OD600 of 1.0 at 
this stage. The overnight culture was then diluted by adding 50 µl of overnight culture to 5 ml of 
fresh media and incubated at 28°C with shaking at 220 rpm for ~1.5 hours. The subcultures were 
then standardized to an OD600 of 0.2.  10 µl of the standardized culture were spotted onto LBS 
plates containing Cm and Tet and incubated for 72 hours at 24°C. All plates used for the 
wrinkled colony assay contain exactly 25 ml of media. Images of the colonies were taken at 24, 
48, and 72 hours using the Zeiss stemi 2000-C dissecting microscope.  
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KV4883-Based Wrinkled Colony Assay 
Any plasmids that resulted in a null phenotype were introduced via conjugation into V. 
fischeri strain KV4883. This strain is a biofilm competent strain that contains a wild-type copy of 
sypQ. Once the mutated plasmid was introduced into KV4883, the strain was grown overnight in 
5 ml of LBS containing Cm and Tet. The cultures were incubated at 28°C with shaking at 220 
rpm. After incubation, the overnight strains were standardized to an OD 600 of 1.0. 50 μl of 
diluted culture was used to inoculate 5 ml of LBS containing Cm and Tet. The inoculated 
cultures were incubated at 28°C with shaking at 220 rpm for ~2.5 hours. After incubation, the 
cultures were standardized to an OD 600 of 0.2. A wrinkled colony assay was performed to 
determine if the mutated protein displayed an inhibitory effect on wild type SypQ. Pictures were 
taken every hour starting at 19 hours and continuing until 24 hours.  
Cell Fractionation Assay 
The cell fractionation protocol utilized is adapted from previously described methods [72, 
73]. 1.5 ml of overnight culture were incubated on ice for 5 minutes and then pelleted at 
16,000xg for 3 minutes at 4°C. the pellet was resuspended in 150 μl of spheroplast buffer (100 
mM Tris pH 8, 0.5 mM EDTA, 0.5 mM sucrose, 20 ug/ml PMSF) and iced for 5 minutes. 50 μl 
was frozen for whole cell fraction. The rest was spun for 3 minutes at 16,000xg and 4°C. The 
supernatant was removed and the pellet was warmed to room temperature and resuspended by 
shaking in 100 μl of ice-cold dH2O and incubated on ice for 45 seconds. 5 μl of 20 mM MgCl2 
was added and the sample was centrifuged for 3 minutes at 16,000xg at 4°C. The supernatant 
was frozen for the periplasm fraction. The pellet was resuspended in 150 μl of cold spheroplast 
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buffer with 15 μl of 2 mg/ml lysozyme and 150 μl of ice-cold dH2O and incubated for 5 minutes 
on ice. After incubation, the sample was centrifuged at 16,000xg at 4°C for 3 minutes. The pellet 
was resuspended in 600 μl of 10 mM Tris pH 8 with 20 μg/ml of PMSF. The sample was then 
frozen and thawed at -80°C three times. 20 μl of 1M MgCl2 and 6 μl of 1 mg/ml DNase was 
added and the sample was centrifuged at 16,000xg at 4°C for 25 minutes. The supernatant was 
frozen for the cytoplasmic fraction. The pellet was resuspended in 50 μl of 10 mM Tris pH 8 
with 2% Triton X-100 and incubated at room temperature for 30 minutes. The sample was 
centrifuged at 16,000xg at 4°C for 25 minutes. The supernatant was frozen for the inner 
membrane fraction. The pellet was resuspended in 50 μl of 10 mM Tris pH 8 and frozen for the 
outer membrane fraction. The samples were then visualized via Western blot (see below). 
Rough Membrane Preparation 
 To isolate a rough membrane fraction from V. fischeri, cells were grown overnight in 
LBS media with Tet and Cm at 28°C with shaking at 220 rpm. After incubation, the cells were 
centrifuged at 13,000xg for 2 minutes. The supernatant was discarded and the pellet was 
resuspended in 250 μl of sample buffer (described below) and lysed via sonication. The sample 
was centrifuged again at 16,000xg at 4°C for 25 minutes. The supernatant was removed and the 
pellet was resuspended in 200 μl of sample buffer. Both the resuspension and the supernatant 
were visualized via Western blot (see below). 
Western Blot Analysis of V. fischeri Strains 
V. fischeri strains carrying the mutated sypQ alleles were grown overnight at 28°C with 
shaking at 225 rpm. 1.5 ml, 5 ml, 10 ml, or 20 ml of the culture was centrifuged at 13,000 rpm 
for 2 minutes. Cells were lysed in 200 μl of 2X sample buffer (4% SDS, 10% β-mercaptoethanol, 
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0.0005% bromophenol blue, 0.1 M Tris pH7, and 2 ml of dH2O). The proteins were separated by 
SDS-PAGE with 150V for 1 hour at 24°C. The samples were loaded onto a 12% acrylamide gel 
(8.6 ml dH2O, 5.0 ml 1.5 M Tris pH 8.8, 200 μl 10% SDS, 9.2l ml 30% Acrylamide, 115 μl 10% 
APS, and 7.5 μl of TEMED).  Proteins were transferred to PVDF membrane with 35V for 16 
hours at 4°C. FLAG -tagged proteins were detected by western blot analysis using anti-rabbit-
anti-FLAG primary antibody (Sigma-Aldrich, St. Louis, MO) followed by an anti-donkey-anti-
IgG secondary antibody (Sigma-Aldrich, St. Louis, MO) conjugated to horseradish peroxidase 
(HRP) and visualized with SuperSignal West Pico Chemiluminescent Substrate (Thermo Fischer 
Scientific, Rockford, IL). 
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Table 1. Strains used in this study. 
Strains  Plasmid(s) Chromosomal Genotype Reference or 
source 
E. coli    
GT115  F- mcrA D(mrr-hsdRMS-
mcrBC) Φ80lacZDM15 
DlacX74 recA1 endA1 Ddcm 
uidA(DMluI)::pir-116 DsbcC-
sbcD 
InvivoGen 
CC130  F-, araD139, delta(ara-
leu)7697 delta lac-74 galU 
galK rpsL 
[74] 
KV5066 pEVS104 lacIQ thi-1 supE44 endA1 
recA1 hsdR17 gyrA462 zei-
298::Tn10 DthyA::(erm-pir-
116) (EmR TcR) 
[63] 
V. 
fischeri 
   
    
KV4700 pARM7, pVSV105 WT Andy Morris 
KV4883 pARM7 (RscS) WT Andy Morris 
KV5452 pARM7, pVAR45 (sypGFLAG) ΔsypE Karen Visick 
KV5562 pARM7  ΔsypQ Satoshi Shibata 
KV5597 pARM7, pVSV105 ΔsypQ Satoshi Shibata 
KV6348 pARM7, pKV471 (sypM FLAG) ΔsypM Karen Visick 
KV7800 pARM7, pCKM1 (sypQFLAG1) ΔsypQ This study 
KV7801 pARM7, pCKM2 (sypQFLAG2) ΔsypQ This study 
KV7802 pARM7, pCKM3 (sypQFLAG3) ΔsypQ This study 
KV7803 pARM7, pCKM4 (sypQFLAG4) ΔsypQ This study 
MF001 pMKF1 (pCKM1 syp promoter) ΔsypQ This study 
MF002 pMKF2 (pMKF1 sypQW29A) ΔsypQ This study 
MF003 pMKF3 (pMKF1 sypQW29E) ΔsypQ This study 
MF004 pMKF4 (pMKF1 sypQD99A) ΔsypQ This study 
MF005 pMKF5 (pMKF1 sypQD99E) ΔsypQ This study 
MF006 pMKF6 (pMKF1 sypQD100A) ΔsypQ This study 
MF007 pMKF7 (pMKF1 sypQD100E) ΔsypQ This study 
MF008 pMKF8 (pMKF1 sypQD116A) ΔsypQ This study 
MF009 pMKF9 (pMKF1 sypQD116E) ΔsypQ This study 
MF010 pMKF10 (pMKF1 sypQD151A) ΔsypQ This study 
MF011 pMKF11 (pMKF1 sypQD151E) ΔsypQ This study 
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MF012 pMKF12 (pMKF1 sypQD236A) ΔsypQ This study 
MF013 pMKF13 (pMKF1 sypQD236E) ΔsypQ This study 
MF1031 pMKF1031 (pMKF1 sypQNM)1 ΔsypQ This study 
MF3241 pMKF3241 (pMKF1 sypQNS)2 ΔsypQ  This study 
MF3342 pMKF3342 (pMKF1 sypQES)3 ΔsypQ This study 
MF3451 pMKF3451 (pMKF1 sypQK89Q) ΔsypQ This study 
MF3741 pMKF3741 (pMKF1 sypQS304P) ΔsypQ This study 
MF4111 pMKF4111 (pMKF1 sypQG322D) ΔsypQ This study 
MF4841 pMKF4841 (pMKF1 sypqY18H) ΔsypQ This study 
MF5111 pMKF5111 (pMKF1 sypQS153L) ΔsypQ This study 
MF5141 pMKF5141 (pMKF1 sypQES) ΔsypQ This study 
MF5241 pMKF5241 (pMKF1 sypQES) ΔsypQ This study 
MF5551 pMKF5551 (pMKF1 sypQL287Q) ΔsypQ This study 
MF5711 pMKF5711 (pMKF1 sypQS153L) ΔsypQ This study 
MF5771 pMKF5771 (pMKF1 sypQNS) ΔsypQ This study 
MF5961 pMKF5961 (pMKF1 sypQNM) ΔsypQ This study 
MF6011 pMKF6011 (pMKF1 sypQA216V) ΔsypQ This study 
MF6021 pMKF6021 (pMKF1 sypQNM) ΔsypQ This study 
MF6121 pMKF6121 (pMKF1 sypQD236N) ΔsypQ This study 
MF6371 pMKF6371(pMKF1 sypQES) ΔsypQ This study 
MF6431 pMKF6431 (pMKF1 sypQY193H) ΔsypQ This study 
MF6441 pMKF6441 (pMKF1 sypQV244A) ΔsypQ This study 
MF6551 pMKF6551 (pMKF1 sypQES) ΔsypQ This study 
MF6611 pMKF6611 (pMKF1 sypQNS) ΔsypQ This study 
MF6841 pMKF6841 (pMKF1 sypQNS) ΔsypQ This study 
MF7341 pMKF7341 (pMKF1 sypQES) ΔsypQ This study 
MF7371 pMKF7371 (pMKF1 sypQG307R) ΔsypQ This study 
MF7511 pMKF7511 (pMKF1 sypQNS) ΔsypQ This study 
MF8041 pMKF8041 (pMKF1 sypQK306E) ΔsypQ This study 
MF8171 pMKF8171 (pMKF1 sypQES) ΔsypQ This study 
MF8261 pMKF8261 (pMKF1 sypQES) ΔsypQ This study 
MF8461 pMKF8461 (pMKF1 sypQES) ΔsypQ This study 
MF8551 pMKF8551 (pMKF1 sypQL26P) ΔsypQ This study 
MF8611 pMKF8611 (pMKF1 sypQD82N) ΔsypQ This study 
MF8911 pMKF8911 (pMKF1 sypQES) ΔsypQ This study 
MF8951 pMKF8951 (pMKF1 sypQNM) ΔsypQ This study 
MF9031 pMKF9031 (pMKF1 sypQNM) ΔsypQ This study 
MF9272 pMKF9272(pMKF1 sypQG346E) ΔsypQ This study 
MF9361 pMKF9361 (pMKF1 sypQN127D) ΔsypQ This study 
MF9461 pMKF9461 (pMKF1 sypQH214Y) ΔsypQ This study 
MF9511 pMKF9511 (pMKF1 sypQK359E) ΔsypQ This study 
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MF9522 pMKF9522 (pMKF1 sypQNS) ΔsypQ This study 
MF9751 pMKF9751 (pMKF1 sypQH214Y) ΔsypQ This study 
MF9831 pMKF9831 (pMKF1 sypQK306E) ΔsypQ This study 
MF10041 pMKF10041 (pMKF1 sypQS323L) ΔsypQ This study 
MF10071 pMKF10071 (pMKF1 sypQY180H) ΔsypQ This study 
MF10271 pMKF10271 (pMKF1 sypQNS) ΔsypQ This study 
MF10462 pMKF10462 (pMKF1 sypQNM) ΔsypQ This study 
MF10831 pMKF10831 (pMKF1 sypQNS) ΔsypQ This study 
MF11151 pMKF11151 (pMKF1 sypQNS) ΔsypQ This study 
MF11231 pMKF11231 (pMKF1 sypQES) ΔsypQ This study 
MF11261 pMKF11261 (pMKF1 sypQY18C) ΔsypQ This study 
MF11511 pMKF11511 (pMKF1 sypQNS) ΔsypQ This study 
MF11751 pMKF11751 (pMKF1 sypQY23H) ΔsypQ This study 
MF11871 pMKF11871 (pMKF1 sypQES) ΔsypQ This study 
1NM = no mutation found in gene 
2NS = not sequenced 
3ES = early stop codon found in gene 
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Table 2. Plasmids used in this study.  
Plasmids Description Reference 
   
pARM7 
 
rscS overexpression plasmid; Tet [59] 
 
pVSV105 
 
Cm Stable Vibrio expression vector  
pCKM1 
 
pVSV105 containing epitope-tagged sypQ 
with tag at AA 36 (lac promotor only) 
This study 
pCKM2 
 
pVSV105 containing epitope-tagged sypQ 
with tag at AA 123 (lac promotor only) 
This study 
pCKM3 
 
pVSV105 containing epitope-tagged sypQ 
with tag at AA 223 (lac promotor only) 
This study 
pCKM4 
 
pVSV105 containing epitope-tagged sypQ 
with tag at AA 292 (lac promotor only) 
This study 
pMKF1 
 
pVSV105 with sypQ-FLAG (syp promotor 
and lac promotor) 
This study 
pMKF2 
 
pMKF1 containing sypQ W29A This study 
pMKF3 
 
pMKF1 containing sypQ W29F This study 
pMKF4 
 
pMKF1 containing sypQ D99A This study 
pMKF5 
 
pMKF1 containing sypQ D99E This study 
pMKF6 
 
pMKF1 containing sypQ D100A This study 
pMKF7 
 
pMKF1 containing sypQ D100E This study 
pMKF8 
 
pMKF1 containing sypQ D116A This study 
pMKF9 
 
pMKF1 containing sypQ D116E This study 
pMKF10 
 
pMKF1 containing sypQ D151A This study 
pMKF11 
 
pMKF1 containing sypQ D151E 
 
This study 
pMKF12 
 
pMKF1 containing sypQ D236A This study 
pMKF13 
 
pMKF1 containing sypQ D236E This study 
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Table 3. Primers used in this study. 
Gene / promoter Sequence 5’ – 3’  Primer  
   
sypA promotor F GCATGCAGCTTCTTCCTTATAGTTATG 1991 
sypA promotor R GTCGACAATAAGCTCCTAGGGAATAATC 1992 
sypQ Gibson F GCCTGCAGGTCGACTCTAGAGAAGGAGCAAATCTATGAATC 1963 
sypQ Gibson R TATAGGGGCGAATTCGAGCTCTTATTTTTGAACTCGAGTCCACG 1964 
sypQ-FLAG 1 F GATTATAAAGATGATGATGATAAA 
AAAGCAATAAAGCCAACCTGTAG 
1955 
sypQ-FLAG 1 R TTTATCATCATCATCTTTATAATC 
TATTGGGTGACGAGAAGCAAAC 
1956 
sypQ-FLAG 2 F GATTATAAAGATGATGATGATAAA 
TTTGAACATAATCGAGGAAAAGTG 
1957 
sypQ-FLAG 2 R TTTATCATCATCATCTTTATAATC 
ATCTAAAATTTCAAAGTGGGTATC 
1958 
sypQ-FLAG 3  GATTATAAAGATGATGATGATAAA 
TCAGATACCATTAATGATGACTTTA 
1959 
sypQ-FLAG 3 R TTTATCATCATCATCTTTATAATC 
CTCTAGATGAATAAATAGCTCGG 
1960 
sypQ-FLAG 4 F GATTATAAAGATGATGATGATAAA 
TACAAAGGAACAGCATTTACCTTT 
1961 
sypQ-FLAG 4 R TTTATCATCATCATCTTTATAATC 
TTTAGGGTTAAACAAGGTAACTAG 
1962 
sypQ W29A F ATACTATTACGCGCTTTTGCTTCTCGTCAC 1999 
sypQ W29A R GTGACGAGAAGCAAAAGCGCGTAATAGTAT 2000 
sypQ W29F F ATACTATTACGCTTTTTTGCTTCTCGTCAC 1997 
sypQ W29F R GTGACGAGAAGCAAAAAAGCGTAATAGTAT 1998 
sypQ D99A F GGATGTACTGCTGAC 2077 
sypQ D99A R GTAACAGTGTCAGCAGTACATCC 2078 
sypQ D99E F GGATGTACTGAAGAC 2075 
sypQ D99E R GTAACAGTGTCTTCAGTACATCC 2076 
sypQ D100A F GTACTGATGCCACTGTTACTATTGCTTATAAC 2001 
sypQ D100A R GTAACAGTGGCACTGTTACTATTGCTTATACC 2002 
sypQ D100E F GTACTGATGAAACTGTTACTATTGCTTATAAC 2003 
sypQ D100E R GTAACAGTTTCACTGTTACTATTGCTTATACC 2004 
sypQ D116A F GCTCTATGTGCAGCTACCCACTTTGAAATT 1995 
sypQ D116A R AATTTCAAAGTGGGTAGCTGCACCGATAGC 1996 
sypQ D116E F GCTCTATGTGCAGAAACCCACTTTGAAATT 1993 
sypQ D116E R AATTTCAAAGTGGGTTTCTGCACCGATAGC 1994 
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sypQ D151A F GCTCTGAGTGCTGTTTCAGCC 2085 
sypQ D151A R GACGGCTGAAACAGCACTCAGAGC 2086 
sypQ D151E F GCTCTGAGTGAAGTTTCAGCC 2083 
sypQ D151E R GACGGCTGAAACTTCACTCAGAGC 2084 
sypQ D236A F CCATTAATGATGCTTTTATTTTAC 2081 
sypQ D236A R GTAAAATAAAAGCATCATTAATGG 2082 
sypQ D236E F CCATTAATGATGAATTTATTTTAC 2079 
sypQ D236E R GTAAAATAAATTCATCATTAATGG 2080 
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CHAPTER THREE 
EXPERIMENTAL RESULTS 
The marine bacterium Vibrio fischeri is the natural symbiont of the Euprymna scolopes 
squid. Initiation of symbiosis is dependent on the production of a biofilm matrix composed of the 
Syp exopolysaccharide (EPS)[53]. The gene locus in V. fischeri that encodes the machinery 
responsible for this EPS component is the symbiotic polysaccharide (syp) locus [8]. This locus 
contains 18 genes (sypA through sypR) that encode regulatory proteins, putative polysaccharide 
exporter proteins, and putative glycosyltransferases. In V. fischeri, SypQ has been identified as 
critical for the formation of wrinkled colonies as well as symbiotic colonization [8, 53]. The 
mechanism by which SypQ contributes to biofilm formation in V. fischeri is currently unknown. 
The goal of this study was to better understand the role of SypQ in biofilm formation. By using 
both a bioinformatics approach and a genetic approach, I intend to identify specific amino acids 
that are important to the ability of the protein to contribute to biofilm formation. If an amino acid 
is necessary for the function of SypQ, then a mutation changing that amino acid will result in a 
loss of function, as indicated by a smooth colony phenotype. 
Bioinformatic Analysis of the sypQ Gene 
 SypQ is a putative glycosyltransferase [7, 8], but the specific function of this protein is 
unknown. There are numerous families of glycosyltransferases with different mechanisms of 
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action. Thus, to better understand the function of SypQ, I used a bioinformatic approach to 
determine the family of GTs to which SypQ belongs, identify the presence of conserved motifs, 
and generate a possible structure for SypQ. The sypQ sequence was first analyzed using NCBI 
BLAST [68], which compares the input sequence to sequences in multiple databases to identify 
regions of similarity. The result suggested that the sypQ gene encodes a family 2 
glycosyltransferase (GT-2) with a putative DxD motif (Figure 3). The prediction also categorizes 
SypQ as a CesA-like protein. The CesA proteins are cellulose synthase-like proteins. These 
proteins all share the common characteristic of elongating polysaccharide chains. Finally, the 
program also indicated that SypQ belongs to the glycosyltransferase GTA-type superfamily 
(glyco_tranf_GTA_type). All of the members of this superfamily contain a specific structural 
similarity, namely, the GT-A fold. Most of the GTs that belong to this superfamily come from 
the family 2 glycosyltransferases. 
I next investigated the structure of SypQ by submitting the amino acid sequence to the 
Phyre 2 bioinformatics server. Phyre 2 utilizes homology modeling, also known as comparative 
modeling. Homology modeling aligns the amino acid sequence of the submitted protein 
sequence, or query, with specific residues of a known and characterized structure. The structure 
on which the query sequence is threaded is chosen based on percent homology. If the query 
sequence has ≥50% homology  to the target sequence, the accuracy of the prediction increases 
[75]. Once the query sequence has been submitted, the server will align the sequence to multiple 
target structures and then rank them based on a raw score that considers both sequence and 
secondary structure similarities.  
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Figure 3.  NCBI BLAST prediction. After submitting the sypQ sequence to the server, the results suggested that 
SypQ is likely a family two glycosyltransferase and contains a putative DxD motif. The region of SypQ that 
contains the putative DxD motif is boxed in red and enlarged to show detail [68].  
 
The top three returns for the SypQ sequence were structures for glycosyltransferases: 
cellulose synthase subunit A (BcsA), mannosyl-3-phosphoglycerate synthase (MngA), and 
polypeptide N-acetylgalactosaminotransferase 1(GALNT1) (Figure 4). All three of the results 
had a confidence of 100.0. The confidence number indicates, on a scale from 1-100, the 
confidence that the query sequence and target structure are homologous. The protein structure 
that the highest percentage of the SypQ query sequence aligned with it was the cellulose 
synthase subunit. Although SypQ had an overall low percentage of sequence homology with all 
three results, this does not necessarily equate to an inaccurate structural prediction. Previous 
work has demonstrated that protein structure is more highly conserved than primary sequence 
[76]. This suggests that distantly related proteins with low sequence homology can still have 
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significant structural homology and thus it is likely that this modeling can reveal insight into 
SypQ.  
The predicted ribbon structure resulting from the threading of the SypQ amino acid 
sequence onto the BcsA structure depicts a globular protein containing multiple alpha helices 
and a central region of comprised of beta sheets (Figure 5). The Phyre 2 structural analysis 
results combined with the NCBI BLAST prediction highly suggests that SypQ is a BcsA-like 
family 2 glycosyltransferase. Because this family of proteins elongates polysaccharide chains via 
an inverting mechanism, the similarity of SypQ to BcsA could indicate that SypQ functions in a 
similar manner to contribute to the production of the exopolysaccharide component of the V. 
fischeri biofilm matrix.  
 
Figure 4. Phyre 2 prediction results. The top three results from the Phyre 2 software are indicated with the 
confidence number in the red box. The percent identity of the query sequence that aligns with the resulting sequence 
is in the second box. The protein to which the query sequence was aligned is in the box titled template information. 
Boxed on the left are the percentage of the query sequence that aligned with the structure of the resulting protein 
[71].  
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Figure 5. The predicted structure of SypQ obtained by submitting the SypQ amino acid sequence to the 
Phyre 2 bioinformatics server. The predicted alpha helices are depicted in pink while predicted beta sheets are 
depicted in yellow. The N-terminal end of the protein is indicated by the blue arrow and the C-terminal end is 
indicated by the green arrow [71]. 
 
To better understand SypQ, I compared it to BcsA. In V. fischeri, BcsA is composed of 
870 amino acid residues and contains 9 putative transmembrane helices while SypQ contains 395 
amino acids and an unknown structure. I utilized protein prediction bioinformatic programs to 
elucidate the topology of SypQ. First, I submitted the SypQ amino acid sequence to the 
PredictProtein software. PredictProtein is a sequence based prediction tool that compares the 
query sequence to multiple sequences from multiple servers to predict secondary structure and 
transmembrane regions within the protein. The prediction suggested that SypQ contains five 
transmembrane helices (Figure 6). Second, I submitted the SypQ sequence to the TOPCONS 
software. The TOPCONS software uses five different topology algorithms to generate a 
consensus prediction. The prediction generated by the SypQ amino acid sequence suggested that 
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the protein has four transmembrane helices (Figure 7). The bioinformatics results suggest that 
SypQ is a membrane-integrated GT-2 and that it potentially shares properties with the well-
characterized GT-2 BcsA. Multiple studies have shown GT-2s to be integrated into both 
eukaryotic and bacterial membranes [77, 78]. Given the bioinformatics results and our 
knowledge that SypQ contributes to the formation of the V. fischeri biofilm exopolysaccharide, I 
hypothesize that SypQ executes its role in exopolysaccharide synthesis from a location in the 
inner membrane. 
 
Figure 6. Putative SypQ transmembrane regions predicted by the PredictProtein server. The amino acid 
position is depicted at the top and the predicted transmembrane regions are depicted below as purple bars. The 
amino acids predicted to be in the TM regions are indicated [69]. 
 
 
Figure 7. Putative SypQ transmembrane regions as predicted by the TOPCONS server. Regions of the protein 
predicted to be outside of the cytoplasm are depicted in blue while regions predicted to be inside the cytoplasm are 
depicted in red. Transmembrane regions thought to traverse the membrane in an outside to inside direction are 
shown as white boxes and those thought to traverse the membrane in an inside-out direction are shown as grey 
boxes. The amino acids predicted to be in the TM regions are indicated [70]. 
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Visualization of Tagged SypQ Via Western Blot Analysis 
 The contribution that SypQ makes to the production of the exopolysaccharide component 
of the V. fischeri biofilm matrix is remains unknown. To more fully understand how SypQ 
promotes biofilm formation it is important to be able to visualize SypQ. Visualization of SypQ 
can answer a variety of questions about the protein. For example, what are the relative SypQ 
protein levels in the cell and does the amount of SypQ present correlate to a change in biofilm 
phenotype? Is the protein being processed (cleaved) in the cell and is the processing essential to 
its function? Is the protein interacting/oligomerizing with other proteins? Where is SypQ located 
in the cell? Thus, one of my goals was to develop tools to visualize SypQ via Western blot 
analysis. 
 To visualize SypQ by Western blot analysis, I first needed to generate a functional 
epitope-tagged version of SypQ. A previous attempt to tag the protein placed a FLAG epitope 
tag at the C-terminal end of the protein. This construct resulted in a protein that was unable to 
restore biofilm formation in a sypQ-deficient V. fischeri strain. As a result, it was necessary to 
insert the epitope tag at an alternate position, one that would permit SypQ to retain its function. 
The ProteinPredict-generated prediction of SypQ’s topology (Figure 6) was used to identify 
regions of the protein that would be potentially permissive to insertion, i.e. regions that lacked 
putative transmembrane sequences, buried residues, and predicted protein-protein interactions. 
Four regions within the protein were identified as possible locations for an internal epitope tag: 
amino acid 36, 123, 223, and 292. sypQ constructs that fused a FLAG epitope tag at those 
positions were generated using PCR SOEing. Sequence analysis confirmed the presence of the 
epitope tag within sypQ. 
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 To determine whether the constructs encoded functional proteins, they were tested for the 
ability to complement a sypQ-deficient strain of V. fischeri. If the epitope-tagged constructs 
encoded functional proteins, then they should restore biofilm formation to a sypQ-deficient 
strain. Specifically, I analyzed biofilm formation using the wrinkled colony assay. Only two of 
the four constructs were able to restore biofilm to the deficient strain (Figure 8).  The constructs 
containing the tag at amino acids 223 and 292 resulted in a loss of function as indicated by a 
smooth colony phenotype. The constructs containing the epitope tag at amino acids 36 and 123 
restored biofilm formation as indicated by the wrinkled colony phenotype and colony stickiness, 
a characteristic that has been attributed to the presence of Syp polysaccharide [7, 8, 79]. While 
the strain containing SypQ with the epitope tag at amino acid 123 had a noticeable delay in 
biofilm formation, the strain containing SypQ with the tag at amino acid 36 displayed a biofilm 
formation similar to that of the positive control. This suggests that the insertion of the FLAG 
epitope tag at this region of the protein has a minimal effect on the protein’s ability to promote 
biofilm formation in V. fischeri. As a result, all experiments moving forward were completed 
using the construct with the tag at amino acid 36. 
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Figure 8. Wrinkled colony assay to determine functionality of tagged SypQ costructs. The four epitope-tagged 
sypQ constructs were introduced into sypQ deficient V. fischeri via triparental conjugation. 10 µl of diluted cell 
culture standardized to an OD600 of 0.2 was spotted onto LBS media containing Cm and Tet. The plates were 
incubated at 24°C and pictures were taken at the time points indicated. Only the sypQ constructs with the tag 
inserted at amino acid 36 (SypQ-FLAG #1) and 123 (SypQ-FLAG #2) restored biofilm formation to the pRscS sypQ 
deficient strain of V. fischeri (KV5562). The sypQ constructs with the tag inserted at amino acid 223 (SypQ-FLAG 
#3) and 292 (SypQ-FLAG #4) did not restore biofilm formation. The negative control is strain KV5597 and the 
positive control is strain KV5709. The experimental strains are 7800-7803 respectively. 
 
Next, I sought to visualize the epitope-tagged SypQ via Western blot using antibodies 
against the FLAG epitope. Having successfully generated a functional epitope-tagged sypQ 
allele, I first attempted to visualize the tagged SypQ protein using a Western blot approach. After 
introducing the plasmid containing the epitope-tagged construct into V. fischeri strain KV5562, 
which is a V. fischeri strain deficient in sypQ, the cells were grown overnight and lysed.  Cells 
expressing either the epitope-tagged SypQ construct or, as controls SypM-FLAG or SypG-
FLAG, were analyzed by Western blot using an anti-FLAG antibody (Figure 9). The epitope-
tagged controls (SypG and SypM) were clearly visible (55 kD and 26 kD respectively); however, 
49 
 
 
 
SypQ, with an expected molecular weight of approximately 46 kD, was not visualized by this 
method.  We hypothesized that low expression of the protein is a possible reason why SypQ was 
not visualized by Western blot. In this construct, sypQ transcription is driven solely by the lac 
promotor. 
 
Figure 9. Western blot analysis of epitope-tagged SypQ construct. Tagged proteins SypQ, SypG, and SypM 
were separated using SDS-PAGE and transferred to a PVDF membrane. An immunoblot assay was performed to 
visualize the proteins using anti-FLAG primary and anti-IgG secondary antibodies. The epitope-tagged controls, 
SypM and SypG were clearly visible but the epitope-tagged SypQ protein was not. The position of the bands of the 
protein standards are indicated by lines and a box on the left-hand side of the blot, and specific sizes for a subset are 
indicated to the left of the blot. 
 
To overcome the possible issue of low expression of SypQ, I inserted the sypA promotor 
upstream of the epitope-tagged sypQ allele. The sypA promotor is the first and best characterized 
of the four promotors within the syp locus. Transcription of the sypA promoter is controlled by 
the transcription factor SypG [54, 56]. This plasmid (pMKF1) was introduced into V. fischeri 
strain KV7720, which is deficient for both sypQ and the negative regulator sypE. The strain also 
overexpresses the syp transcription factor SypG from plasmid pCLD56. The absence of the 
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negative regulator and an abundance of the native transcription factor should increase the level of 
transcription from the sypA promoter, potentially resulting in higher levels of protein and an 
increase in signal. However, under these conditions. I was unable to visualize SypQ via Western 
blot (data not shown). It is known that SypQ participates in biofilm formation. I hypothesized 
that by using conditions that induce biofilm formation, I could increase the transcription of sypQ 
and, therefore, increase the levels of SypQ present in the cell. Thus, I induced biofilm formation 
in liquid cultures via the addition of 10 mM or 20 mM of CaCl2 (Lie, Tischler, and Visick 
submitted). Cells within the syp-dependent clump that contained the SypQ-FLAG protein or the 
positive control, SypM-FLAG, were lysed and analyzed by Western blot using an anti-FLAG 
antibody. The epitope-tagged SypQ protein was not visible in any of the lanes, regardless of 
CaCl2 concentration.  
Another possibility for the lack of visible protein is that sypQ transcription may only 
occur early after biofilm induction, resulting in the production of protein at time points that are 
earlier than I have assessed to date. To determine if this were the case, the assay was repeated 
and samples were taken and processed at hourly intervals for eight hours after the addition of 
calcium (Figure 10). Similar to previous results, SypQ was not visible at any of the intervals. 
 
 
 
51 
 
 
 
 
Figure 10. Western blot of epitope-tagged SypQ at hourly time points. V. fischeri cells carrying the epitope-
tagged sypQ construct were treated with 20 mM calcium chloride. At one-hour intervals for 8 hours, 1.5 ml of cell 
culture was centrifuged and lysed via sonication. The proteins from the lysate were separated via SDS-PAGE and 
visualized by Western blot using an anti-FLAG primary antibody and an anti-IgG secondary antibody. The lanes are 
numbered one through ten at the top with the corresponding time point above. The position of the bands of the 
protein standards are indicated by lines and a box on the left-hand side of the blot, and specific sizes for a subset are 
indicated to the left of the blot. 
 
Given my hypothesis that SypQ functions from a location in the inner membrane, I 
performed cell fractionation experiments to concentrate SypQ in the inner membrane fraction 
and thus amplify the signal. Using the fractionation technique described in the methods section, 
lysates of cells containing the epitope-tagged construct were separated into cytoplasmic, inner 
membrane, periplasmic, and outer membrane fractions, and then analyzed by Western blot. If 
SypQ is located in the inner membrane, it should be concentrated in that fraction and the signal 
will be amplified. This should allow for visualization. The epitope-tagged SypG and SypM 
proteins were used as a positive control for the cytoplasmic and membrane fractions respectively, 
but were instead visible in the wrong fractions (SypG was present in the inner membrane and 
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periplasmic fractions while SypM was detected in the periplasm), suggesting that the 
fractionation was not clean. Regardless, the epitope-tagged SypQ protein was still not visible in 
any of the fractions (Figure 11). 
 
Figure 11.  Cellular fraction of V. fischeri to visualize SypQ via Western blot. V. fischeri cells carrying the 
epitope-tagged sypQ allele were separated into the cytoplasmic, inner membrane, periplasmic, and outer membrane 
fractions using the described protocol. The fractions were resolved by SDS-PAGE and the proteins were visualized 
by Western blot using an anti-FLAG primary antibody and an anti-IgG secondary antibody. The lanes containing 
epitope-tagged SypQ, SypG, and SypM are labeled Q, G, and M respectively. The different cell fractions 
[cytoplasmic (cyto), inner membrane (inner), periplasm (peri), and outer membrane (outer)] are labeled above. The 
position of the bands of the protein standards are indicated by lines and a box on the left-hand side of the blot, and 
specific sizes for a subset are indicated to the left of the blot. 
 
Finally, I attempted an enrichment technique to isolate SypQ: rather than separating the 
cells into the four fractions, I attempted to isolate a rough membrane fraction by utilizing a rough 
membrane extraction protocol. The simplified protocol could minimize the loss of product, 
leading to a more concentrated SypQ sample. The process was performed with 5 ml, 10 ml, and 
30 ml of overnight culture. Extract from the lower 5 ml cell volume showed no signal on the gel, 
while extracts from the larger cell volumes displayed a large smear throughout the gel (Figure 
12). In this assay, the tagged SypM positive gave no visible signal, suggesting that the cellular 
preparation was not optimal. Visualization of the tagged SypQ protein was unsuccessful. In the 
Discussion, I will address some possible reasons why the protein was not detectible by Western 
blot. 
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Figure 12. Western blot of rough membrane fraction to visualize SypQ. Different volumes of V. fischeri cells 
carrying the epitope-tagged sypQ allele (5 ml, 10 ml, or 30 ml) were separate into a pellet containing the rough 
membrane fraction and the supernatant. The proteins from both the pellet (pel) and the supernatant (sup) were 
separated by SDS-PAGE and visualized via Western blot using an anti-FLAG primary antibody and an anti-IgG 
secondary antibody. The epitope tagged SypM control is labeled M in lane 2. Lanes 3-8 contain proteins from the 
supernatant or pellet of the different volumes (indicated above). The position of the bands of the protein standards 
are indicated by lines and a box on the left-hand side of the blot, and specific sizes for a subset are indicated to the 
left of the blot. 
 
Site-Directed Mutagenesis of sypQ 
Identification of Putative Functional Motifs in SypQ. 
 Despite my inability to visualize SypQ, I proceeded to investigate this protein via a 
structure/function analysis. This approach will lay the groundwork for an understanding of 
SypQ’s function. I began by examining the amino acid sequence for the presence of potential 
conserved residues. To identify essential amino acid residues in SypQ, I utilized the previous 
bioinformatics findings and primary sequence alignments with characterized GT-2 enzymes. The 
Phyre 2 results suggested that SypQ has a high amount of structural similarity with the family 2 
glycosyltransferase protein BcsA, despite a low amount of sequence similarity. Previous research 
identified functional motifs that are essential to the function of family 2 glycosyltransferases [9, 
13, 19]. There are four particular sequence motifs that contribute to the function of this family of 
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GTs: DDx, DxD/DxH, TED, and Q/LxxRW motifs each have roles critical to the function of the 
enzyme. I hypothesized that if SypQ is a GT-2, then it may contain some or all of these 
functional motifs. To determine if any of these motifs were present, I compared SypQ and BcsA. 
Specifically, I aligned the SypQ sequence from the V. fischeri strain ES114 with the BcsA 
sequence from V. fischeri, E. coli, and S. typhimurium (Figure 13) by submitting all of the amino 
acid sequences to the Clustal omega server [66]. I then examined the alignment to identify the 
motifs in BcsA and to determine if one or more of the motifs were present in SypQ. As described 
in more detail below, I identified regions of SypQ sequences that closely resembled known GT-2 
functional motifs, including potential DDX, DxD/DxH, TED, and Q/LxxRW sequences. 
Although not fully conserved, the presence of these motifs is consistent with my hypothesis that 
SypQ functions as a GT-2. 
 DDx has been shown to be critical for the ability of GT-2s to catalyze the formation of 
both α- and β- glycosidic bonds [17]. The DDx motif is located adjacent to the DxD motif in the 
active site of the 3-dimensional structure, where it interacts with the anomeric side of the donor 
sugar. In my analysis of the SypQ sequence, I found a sequence, TDDT (residues 98-101, 
highlighted in yellow in Figure 13), that could serve as either a TED (TDD) or as a DDx (DDT) 
motif. While neither putative motif specifically aligns with the known motif of BcsA, the 
sequence is located very close to a known DDx motif in BcsA (DDG). As a result, I hypothesize 
that one or both of the aspartates (D99 and D100) may be important for SypQ function. 
 The role of the DxD functional motif has been well characterized in BcsA. This motif is 
present in the active site, where it interacts with the phosphate of the nucleotide donor molecule 
and coordinates the divalent cations needed for the function of BcsA [11, 19, 20]. As described 
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above, my original BLAST alignment identified a DxD motif (Figure 3). However, when I align 
SypQ with BcsA, the corresponding sequence motif in SypQ, located at amino acids D151-S153, 
is DVS (highlighted in blue in Figure 13).  Although the sequence in SypQ is not an exact match 
to the corresponding sequence in the BcsA sequences, it is located at the same location and the 
primary aspartic acid is highly conserved. For these reasons, I hypothesize that the DVS 
sequence in SypQ is, in fact, functioning like the DxD motif. If so, then I predict that the aspartic 
acid residue (D151) will be essential to the function of SypQ. Experiments designed to test this 
possibility are described below.   
As mentioned in chapter one, the DxD motif is sometimes replaced with a DxH. A 
putative DxH sequence is located from amino acids 116 to 118 (D116, T117, D118) in SypQ. 
While the DTH sequence in SypQ is not located at or near any known functional motifs in BcsA, 
when located on the Phyre-predicted ribbon diagram, the D116 residue is located very close to 
the beta sheets that make up the predicted active site (Figure 14). I hypothesize that, because of 
its closeness to the predicted active site, the SypQ DTH sequence may contribute to the function 
of the protein. 
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Figure 13. Alignment of SypQ with BcsA. The SypQ amino acid sequence from V. fischeri was aligned with the 
BcsA amino acid sequence from V. fischeri (Q5DZ42-1), E. coli (P37653-1), and S. typhimurium (Q93IN2-1). SypQ 
sequence with similarity to known GT-2 functional motifs are underlined. The amino acid residues targeted for 
mutagenesis are in bold. There are multiple amino acid residues in SypQ that are conserved in BcsA. These residues 
are designated by an asterisk (*).  The known functional motifs in BcsA are highlighted in yellow (DDX), blue 
(DxD), grey (TED), and green (Q/LxxRW) with the name of the motif printed above underlined and in bold. All 
sequences attained from Uniprot [80]. 
 
The next motif of interest is TED. The TED motif interacts with the acceptor molecule 
growing polysaccharide chain through hydrogen bonding [11, 20]; this motif sequence is 
somewhat variable in cellulose synthase-like proteins, sometimes being replaced with TDD. I 
identified a sequence, NDDF (residues 234-237, highlighted in gray in Figure 13) that could 
function as either a TED motif (TDD) or a DDx motif (DDF). Although the TED/TDD sequence 
is not fully conserved, it is positioned at the same location as the known TED in BcsA. Due to 
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the alignment of the NDD sequence with the TED/TDD sequence of BcsA, I hypothesize that 
D236 is important to SypQ function. 
Finally, the Q/LxxRW motif in BcsA is essential and may partner with the DxD motif 
residues to facilitate cellulose synthesis. In this motif, the tryptophan residue is located directly 
above the active site and interacts with the accepter end of the polymer chain while the arginine 
residue, like the aspartic acid in the DxD motif, is in contact with the donor molecule’s 
phosphate group [13, 14, 20]. In BcsA, the motif is located towards the C-terminal end of the 
protein and is located above the active site in the 3-dimensional structure. No such sequence is 
present in the C-terminus of SypQ as SypQ ends prior to the established Q/LxxRW sequence in 
BcsA (Figure 13). However, a similar sequence, ILLRW (I25-W29), is located near the N-
terminal end of the protein. Given the different position, it is not clear if this sequence in SypQ 
would function as it does in BcsA, however, the motif sequence is mostly conserved: the 
arginine and tryptophan match the sequence of the known motif and there is a conservative 
change of the leucine residue to an isoleucine. Due to the relative conservation of the sequence, I 
chose to investigate the possibility that this sequence in SypQ represents a true Q/LxxRW motif. 
If this is a true Q/LxxRW motif, then I hypothesize that the tryptophan residue contributes to the 
function of SypQ.   
I then aligned the SypQ amino acid sequence with sequences from other processive GT-
2s (Figure 14).  I aligned SypQ with NodC from Rhizobium meliloti and AscA from 
Komagataeibacter xylinus. NodC is a glycosyltransferase essential for chitin synthase and AscA 
is utilized for cellulose synthase. As with BcsA, the known sequence motifs are present in both 
NodC and AcsA.  
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Figure 14. Alignment of SypQ with NodC and AcsA. The SypQ amino acid sequence from V. fischeri was 
aligned with the AcsA amino acid sequence from K. xylinus (P0CW87), and NodC from R. meliloti (P04341). SypQ 
sequence with similarity to known GT-2 functional motifs are underlined. The amino acid residues targeted for 
mutagenesis are in bold. There are multiple amino acid residues in SypQ that are conserved in AcsA and NodC. 
These residues are designated by an asterisk (*).  The known functional motifs in BcsA are highlighted in yellow 
(DDX), blue (DxD), grey (TED), and green (Q/LxxRW) with the name of the motif printed above underlined and in 
bold. All sequences attained from Uniprot [80]. 
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Figure 15. Location of putative functional motifs on predicted SypQ structure. The predicted alpha 
helices are depicted in pink while predicted beta sheets are depicted in yellow. The N-terminal and C-terminal ends 
are indicated by arrows. The location of the putative functional motifs is circled in yellow and the targeted amino 
acids are identified in white text. 
 
I tested my hypotheses that the putative motifs identified in SypQ do, in fact, represent 
functional motifs by identifying residues to be targeted for site-directed mutagenesis and then 
designing and generating SypQ mutants. To determine if the targeted residues in the putative 
functional motifs are essential to the function of SypQ, I generated sypQ alleles containing single 
point mutations at the indicated amino acid residues (Figure 15). For the targeted aspartic acid 
residues, I hypothesized that the charge of the residue is necessary for the function of the protein. 
If so, then changing the aspartic acid to glutamic acid should result in little or no change in 
biofilm formation while an alanine substitution should result in a severe biofilm defect. 
Therefore, I designed my experiments to change each targeted aspartic acid to an alanine and a 
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glutamic acid. For the targeted tryptophan residue, I hypothesized that the large side chain of 
tryptophan may be important to its function. If that is true, then changing it to phenylalanine 
(which also has a large side chain) would result in little to no loss of biofilm formation, while an 
alanine substitution would result in partial to total loss of biofilm.  Thus, for W29, I designed 
experiments to generate both alanine and phenylalanine substitutions. 
 
Figure 16. List of amino acids targeted for site-directed mutagenesis and proposed mutations. At the top of 
each pyramid is the SypQ sequence similar to known GT-2 functional motifs with its corresponding motif sequence 
in parentheses. Below that, the suggested residue substitutions are indicated in red and the name of the mutation is in 
blue. 
 
Generation and Evaluation of Site-Directed Mutants. 
To introduce the proposed amino acid substitutions into the epitope-tagged sypQ allele, I 
designed primers containing the codon changes and used PCR SOEing to generate the mutated 
alleles. Then, I ligated the mutated sequences into pMKF1 in place of the wild type sypQ and 
introduced the resulting plasmid into the KV5562, a sypQ mutant strain that also contains 
plasmid pARM7, which overexpresses the positive biofilm regulator RscS: the two plasmids are 
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fully compatible.  Finally, I determined whether the mutated sypQ allele could restore biofilm 
formation to the sypQ deficient strain using the wrinkled colony assay (Figure 16). Wrinkled 
colony architecture and colony cohesion (stickiness) are used as a readout for biofilm formation 
and polysaccharide production respectively.  
I used two positive controls: (i) a sypQ mutant that carries pARM7 (for overexpressing 
RscS) and pMKF1, which contains unmutated sypQ (strain MF001), and (ii) a wild type V. 
fischeri strain that carries pARM7 and pVSV105 (the vector control corresponding to pMKF1) 
(strain KV4700). For a negative control, the sypQ mutant overexpressing RscS and carrying the 
pVSV105 vector was used (strain KV5597). Both positive control strains displayed wrinkled 
colony formation within 24 hours, and exhibited high cohesiveness at the last time point (Figure 
16A). In contrast, and as expected because sypQ had been previously shown to be critical for 
wrinkled colony formation [7], the negative control failed to produce any colony architecture for 
the duration of the time course, and it lacked cohesiveness at the final time point.  
Of the six putative functional motifs in SypQ, only mutations to two of them failed to 
affect wrinkled colony formation (Figure 16B). These two were changes to D99 and D100, the 
putative TED and C-terminus DDx motifs that overlap at these two aspartic acid residues. Both 
the alanine and the glutamate mutations to these amino acids failed to affect biofilm formation. 
With these amino acid substitutions, SypQ restored normal wrinkled colony formation and 
polysaccharide production to the sypQ deficient V. fischeri. This suggests that the D99 and D100 
amino acid residues are not essential to the function of SypQ and that this region of SypQ 
primary sequence does not represent a functional motif. 
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In contrast, mutations to the putative DxH motif had a noticeable effect on both the 
timing of biofilm formation and the cohesiveness of the colony. The D116A and D116E 
mutations to SypQ resulted in a diminished biofilm phenotype when the mutated protein was 
expressed in a sypQ-deficient V. fischeri.  However, the D116A mutation was slightly more 
deleterious than the D116E; D116A resulted in a lack of surface architecture while still 
facilitating a mild amount of colony cohesion, whereas, D116E resulted in diminished (but 
present) surface architecture and colony cohesion. 
The LxxRW motif in SypQ displayed two different phenotypes when mutated. When the 
tryptophan was mutated to a phenylalanine (W29F), there was no effect on the formation of 
biofilm in either timing or polysaccharide production. The alanine substitution (W29A), 
however, resulted in a null phenotype. The colony lacked both surface architecture and 
cohesiveness. Since the phenylalanine substitution is a conservative change, the difference in 
phenotype suggests that the tryptophan residue is not essential but the structure to which it 
contributes is essential. I will discuss possible reasons for the contrasting phenotypes in the 
Discussion section. 
Mutations to the remaining two possible SypQ motifs resulted in a complete abrogation 
of biofilm formation. Glutamic acid and alanine substitutions to the aspartic acid (D151) in 
SypQ’s putative DxD motif resulted in a smooth colony with no polysaccharide. The same result 
was achieved when the same substitutions were made to the aspartic acid residue (D236) in the 
C-terminal TED/DDx motif in SypQ. The severity of the phenotype regardless of residue 
substitution suggests that these amino acids are critical to the function of SypQ and could be 
located within functional motifs. 
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Figure 17. Wrinkled colony assay of site-directed sypQ mutants. A. Two positive controls were used. The wild 
type control is a V. fischeri strain that expresses a wild type SypQ from the chromosome, overexpresses RscS, and 
carries the vector control plasmid. The other positive control is a sypQ deficient strain that overexpresses RscS and 
carries the unmutated pMKF1 plasmid. B. Plasmids carrying the sypQ allele with the site-directed mutations were 
introduced into a sypQ deficient strain of V. fischeri. A wrinkled colony assay was performed over a 72-hour time 
course. At 72 hours, the spots were disrupted to assay for the presence of polysaccharide. 
 
 
Random Mutagenesis of SypQ 
 The results from the site-directed mutagenesis identified four amino acid residues that are 
essential for the function of SypQ. However, SypQ contains 395 amino acids. To globally 
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identify which amino acids in SypQ are essential for its function, I randomly mutated the 
epitope-tagged sypQ allele. To generate random mutations into the sypQ allele, I passaged the 
pMKF1 plasmid through the mutator E. coli strain CC130. I then introduced the mutated plasmid 
into KV5562, a sypQ deficient strain of V. fischeri that overexpresses the sensor kinase RscS. 
Finally, I performed wrinkled colony assays to identify possible sypQ mutants and identified 
plasmid-based mutations (potentially in sypQ) by backcrossing into the parent strain the plasmid 
from any strains that displayed an altered biofilm phenotype. To reduce the incidence of 
identifying sibling mutants, I performed 148 independent mutageneses. From those experiments, 
I isolated 52 original mutants that retained their mutant phenotype after back-crossing: in the 
Discussion section, I will elaborate upon the possible reasons for the relatively poor yield of 
mutants following back-cross. 
I next categorized the resulting mutants into one of three groups: delayed phenotype, 
diminished phenotype, and smooth phenotype. The delayed phenotype mutants demonstrated a 
delay in the onset of biofilm formation at 24 hours compared to the positive control. By 72 
hours, however, the delayed mutants achieved wrinkling and colony stickiness at levels 
comparable to the positive control. The diminished phenotype mutants demonstrated both a 
delay in biofilm formation and a reduction in wrinkling and colony cohesion compared to the 
positive control. The smooth phenotype mutants showed a complete loss of biofilm indicated by 
a lack of both wrinkles and polysaccharide, giving them a phenotype similar to the negative 
control. Of the confirmed mutants, 5, 24, and 26 were classified as delayed, diminished, and 
smooth, respectively. As described in more detail below, I sequenced a subset of these mutants: 
when mutants with similar phenotypes were obtained from the same original mutagenesis, I 
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chose to sequence only one, to avoid re-sequencing possible siblings. Furthermore, knowing that 
the delayed and diminished mutants made at least some SypQ protein, I focused my initial 
sequencing on these mutants rather than the smooth, anticipating that the smooth mutants may 
not produce the SypQ protein for any of a variety of reasons. 
 To determine the nature of the mutation in both the delayed phenotype and diminished 
phenotype mutants, I sequenced the mutated alleles using ACGT (Wheeling, IL). The five 
delayed phenotype mutants had differing mutations (Figure 17). The most informative were 
mutants 4111, 4841, and 6441 which all had single point mutations: G322D, Y18H, and V244A 
respectively. In contrast, the other two were less informative: mutant 11871 had a single guanine 
to adenosine transition mutation in codon 79, resulting in a tryptophan being mutated to a stop 
codon, while 5961 had no discernable mutation in sypQ (Table 4). I conclude that G322, Y18, 
and V244 make contributions to SypQ function and /or stability. I will discuss possible 
explanations for the other delayed phenotype mutations in the Discussion section. 
Table 4. Randomly generated delayed mutants 
Name Mutagenesis1 Plate2 Isolate3 Mutation 
4111 41 1 1 g-a mutation = G322D 
4841 48 4 1 t-c mutation = Y18H 
5961 59 6 1 no genuine mutations found in gene 
6441 64 4 1 t-c mutation = V244A 
11871 118 7 1 g-a mutation = W41UGA early stop 
codon 
1Mutagenesis refers to the specific number of the independent conjugation from which each mutant was 
obtained. 
2Plate refers to the number of the plate from the independent conjugation. 
3Isolate refers to the number of the isolate from the individual plate. 
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Figure 18. Wrinkled colony assay of the randomly generated delay phenotype mutants. A. Two 
positive controls were used. The wild type control is a V. fischeri strain that expresses a wild type SypQ from the 
chromosome, overexpresses RscS, and carries the vector control plasmid. The other positive control is a sypQ 
deficient strain that overexpresses RscS and carries the unmutated pMKF1 plasmid. B. Plasmids carrying randomly 
mutated sypQ allele were introduced into a sypQ deficient strain of V. fischeri. A wrinkled colony assay was 
performed over a 72-hour time course. Time points at which the pictures were taken are indicated above. At 72 
hours, the spots were disrupted to assay for the presence of polysaccharide. 
 
 24 randomly generated mutants displayed a diminished phenotype. These mutants 
displayed both decreased colony cohesion and wrinkled colony architecture at 72 hours (Figure 
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18). Of these, nine contained single point mutations resulting in informative codon changes. Two 
of the mutants (10041and 11751) had a point mutation in predicted transmembrane regions 
(S323L and Y23H respectively) while two others (9831 and 9511) had point mutations near 
potential transmembrane regions (K306E and K359E respectively). The remaining five had 
mutations in different regions of the predicted large exposed region of the protein. Specifically, 
mutants 8611, 9361, and 5551 encoded SypQ proteins with codon changes D82N, N127D, and 
L287Q respectively. Mutants 9461 and 9751 each contained an independent mutation in H214Y 
(Table 5). 
The remaining 15 mutants were much less informative. Three contained no mutations 
within the sypQ, while eight contained a nucleotide insertion that resulted in an early stop codon, 
similar to the phenomenon observed for the delayed mutants. Of the stop codon mutants, five 
mutants, (5141, 5241, 6371, 7341, and 11231) all had an adenosine insertion in a run of 
adenosines, while two mutants (8171 and 8261) each had the same cytosine insertion at 
nucleotide 105. Mutant 6551 had a cytosine insertion at nucleotide 1456. In the Discussion 
section, I will speculate on the possible reasons why the mutants containing stop codons were 
able to produce diminished biofilms and why three of the mutants had no visible mutations in the 
sypQ gene. 
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Figure 19. Wrinkled colony assay of randomly generated diminished phenotype mutants. A. Two 
positive controls were used. The wild type control is a V. fischeri strain that expresses a wild type SypQ from the 
chromosome, overexpresses RscS, and carries the vector control plasmid. The other positive control is a sypQ 
deficient strain that overexpresses RscS and carries the unmutated pMKF1 plasmid. B. Plasmids carrying randomly 
mutated sypQ allele were introduced into a sypQ deficient strain of V. fischeri. A wrinkled colony assay was 
performed over a 72-hour time course. Time points at which the pictures were taken are indicated above. At 72 
hours, the spots were disrupted to assay for the presence of polysaccharide. 
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Figure 19 (cont.). Wrinkled colony assay of randomly generated diminished phenotype mutants. A. 
Two positive controls were used. The wild type control is a V. fischeri strain that expresses a wild type SypQ from 
the chromosome, overexpresses RscS, and carries the vector control plasmid. The other positive control is a sypQ 
deficient strain that overexpresses RscS and carries the unmutated pMKF1 plasmid. B. Plasmids carrying randomly 
mutated sypQ allele were introduced into a sypQ deficient strain of V. fischeri. A wrinkled colony assay was 
performed over a 72-hour time course. Time points at which the pictures were taken are indicated above. At 72 
hours, the spots were disrupted to assay for the presence of polysaccharide. 
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Table 5. Randomly generated Diminished mutants. 
 
Name1 Mutagenesis Plate Isolate mutation 
     
1031 10 3 1 No mutation found in 
gene 
3451 34 5 1 a-c mutation = K89Q 
5141 51 4 1 a insertion at nucleotide 
171 = early stop codon 
5241 52 4 1 a insertion at nucleotide 
171= early stop codon 
5551 55 5 1 t-a mutation = L287Q 
6021 61 2 1 no mutations found in 
gene 
6371 63 7 1 a insertion at nucleotide 
171 = early stop codon 
6551 65 5 1 c insertion at nucleotide 
987 = early stop codon 
7341 73 4 1 a insertion at nucleotide 
131 = early stop codon 
8041 80 4 1 a-g mutation = K306E 
8171 81 7 1 c insertion at nucleotide 
105 = early stop codon 
8261 82 6 1 c insertion at nucleotide 
105 = early stop codon 
8611 86 1 1 g-a mutation = D82N 
8951 89 5 1 no mutations found in 
gene 
9031 90 3 1 no mutations found in 
gene 
9361 93 6 1 a-g mutation = N127D 
9461 94 6 1 c-t mutation = H214Y 
9511 95 1 1 a-g mutation = K359E 
9751 97 5 1 c-t mutation = H214Y 
9831 98 3 1 a-g mutation = K306E 
10041 100 4 1 c-t mutation = S323L 
11231 112 3 1 a insertion at nucleotide 
171 = early stop codon 
11751 117 5 1 t-c mutation = Y23H 
1Mutagenesis, plate, and isolate terms are as defined in Table 4. 
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 The remainder (24) of the randomly generated mutations resulted in a smooth colony 
phenotype (Figure 19). The smooth mutation phenotype mutants are the most informative in that 
they result in the most defective phenotype; thus, knowing the nature of the mutations in the 
smooth mutants can give us the most insight into the function of SypQ. However, the null 
phenotype of the smooth mutants could also be due the loss of SypQ production through several 
possible mechanisms. For example, the mutation introduced into the gene by the CC130 mutator 
E. coli cells could have been a point mutation resulting in an early stop codon. The mutation 
could be in the promotor region resulting in loss of transcription. Another possibility is that the 
mutation is a point mutation that affects the stability of the protein.  
 Usually, Western blots are used to distinguish between mutations that affect protein 
production/stability and those that do not. However, given my inability to visualize the epitope-
tagged SypQ protein via Western blot, this approach was not possible for SypQ. Therefore, I 
attempted another method to determine if the protein was being produced. I hypothesized that if 
a mutant SypQ protein is, in fact, made, then the presence of the defective protein could 
potentially interfere with the function of a wild-type protein (Figure 20). If that were the case, 
then the mutant protein could potentially cause a delay in biofilm formation in an otherwise 
biofilm-competent strain. Such a result would provide evidence that the mutated protein is 
indeed being produced. 
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Figure 20. Wrinkled colony assay of randomly generated smooth phenotype mutants. A. Two positive 
controls were used. The wild type control is a V. fischeri strain that expresses a wild type SypQ from the 
chromosome, overexpresses RscS, and carries the vector control plasmid. The other positive control is a sypQ 
deficient strain that overexpresses RscS and carries the unmutated pMKF1 plasmid. B. Plasmids carrying randomly 
mutated sypQ allele were introduced into a sypQ deficient strain of V. fischeri. A wrinkled colony assay was 
performed over a 72-hour time course. Time points at which the pictures were taken are indicated above. At 72 
hours, the spots were disrupted to assay for the presence of polysaccharide. 
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Figure 20 (cont.). Wrinkled colony assay of randomly generated smooth phenotype mutants. A. Two 
positive controls were used. The wild type control is a V. fischeri strain that expresses a wild type SypQ from the 
chromosome, overexpresses RscS, and carries the vector control plasmid. The other positive control is a sypQ 
deficient strain that overexpresses RscS and carries the unmutated pMKF1 plasmid. B. Plasmids carrying randomly 
mutated sypQ allele were introduced into a sypQ deficient strain of V. fischeri. A wrinkled colony assay was 
performed over a 72-hour time course. Time points at which the pictures were taken are indicated above. At 72 
hours, the spots were disrupted to assay for the presence of polysaccharide. 
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Figure 21. Depiction of SypQ co-expression assay. To determine if the mutated protein is being produced, the 
randomly mutated plasmids from smooth phenotype mutants were introduced to a V. fischeri strain carrying a wild 
type chromosomal sypQ allele. If the mutated protein is being made, then it will compete with the wild type SypQ 
protein and lead to a delay in biofilm formation.   
 
 To determine if any of the smooth phenotype mutants produced a stable SypQ protein 
that was present in the cell, I introduced plasmids with mutated sypQ alleles into KV4883. This 
strain contains a wild type sypQ allele in its native position in the chromosome. As proof of 
principle, I began by assessing the site-directed mutants, as I already knew the nature of their 
mutations (and that none of the alleles encoded proteins containing an early stop codon). I then 
assessed biofilm formation via the wrinkled colony assay (Figure 21). I found that eight of the 12 
mutations caused a small delay in biofilm formation compared to the positive controls. 
Specifically, at 21 hours, the positive controls and four of the mutants (W29F, W29A, D99E, and 
D100A) began to wrinkle, while the others remained smooth. The D99A, D151A, D116E, 
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D116A, D236A, and D100E mutations all resulted in moderate, ~1 hour, delay in the onset of 
biofilm formation. The D151E and D236E mutations resulted in a more severe, ~2-3 hour, delay. 
These mutants did not display wrinkling until 23 and 24 hours, respectively. From these data, I 
conclude that the mutations with a severe delay (D151E and D151A) are producing protein at 
high enough levels as to interfere with the wild type protein. The lack of delay in the W29F, 
W29A, D99E, and D100A mutants could be due to a few reasons: it is possible that no protein is 
made, that it is made but unstable and easily degraded, or that it is made but is defective in 
substrate binding or protein-protein interaction.  
Next, I introduced into KV4883 the mutated plasmids from 24 randomly generated 
smooth phenotype strains. 14 of the 26 demonstrated delayed biofilm formation relative to the 
controls (Figure 22). 12 of the mutants began wrinkling at 21 hours similar to the positive 
controls, thus I cannot make any conclusions about whether SypQ protein is made. In contrast, 
ten of the mutants had a modest, ~ 1 hour, delay and four had a slightly more severe, ~2 hour, 
delay. Based on these results, I conclude that these latter 14 may be producing a mutant SypQ 
protein that is inhibiting the action of the wild type SypQ. To identify the nature of the mutation 
in these mutants, I submitted the plasmids for sequencing. As shown in Table 6, two of the 
mutants (8461 and 8911) had an adenosine deletion at a run of adenosines that resulted in an 
early stop codon. One mutant, 3342, had both a point mutation (L228P) and an early stop codon 
as a result of a tyrosine insertion at nucleotide 928. Mutant 3342 had no apparent mutation found 
within the gene. The remaining ten mutants had single point mutations at various regions within 
sypQ (Table 6). Three of the mutations, G346, L26P, and Y18H, were located in putative 
transmembrane regions (9271, 8551, and 11261 respectively), while mutants 3741 and 7371 had 
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mutations located near transmembrane regions (S304P and G307R, respectively). Mutants 6011, 
6431, and 10071 all had point mutations located in the central region of the protein (A216V, 
Y193H, and Y180H, respectively). Interestingly, two of the mutants contained point mutations in 
two of the identified putative functional motifs in SypQ (S153L and D236N, respectively). 
Possible reasons why these mutations contribute to a null phenotype are discussed to a greater 
extent in the Discussion section.  
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Figure 22. Expression of site-directed mutants in wild type V. fischeri. A. Two positive controls were used: a 
wild type V. fischeri overexpressing RscS and carrying the pVSV105 vector control plasmid and a wild type V. 
fischeri overexpression RscS and carrying the unmutated pMKF1 plasmid. B. The plasmid containing the site-
directed mutations were introduced into wild type V. fischeri overexpressing RscS and a spotting assay was done. 
The identity of the point mutation is indicated to the left side while the time at which the pictures were taken is 
indicated above.   
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Figure 23. Expression of randomly generated smooth phenotype mutants in wild type V. fischeri. A. Two 
positive controls were used: a wild type V. fischeri overexpressing RscS and carrying the pVSV105 vector control 
plasmid and a wild type V. fischeri overexpression RscS and carrying the unmutated pMKF1 plasmid. B. The 
plasmid containing the randomly generated mutations were introduced into wild type V. fischeri overexpressing 
RscS and a spotting assay was done. The identity of the random mutant is indicated to the left side while the time at 
which the pictures were taken is indicated above. 
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Table 6. Randomly generated smooth phenotype mutants 
 
Name Mutagenesis Plate Isolate mutation 
     
3342 33 4 2 t-c mutation = L228P/ t insertion = early stop codon at 
amino acid 327 
3741 37 4 1 t-c mutation = S304P 
5111 51 1 1 c-t mutation = S153L 
5711 57 1 1 c-t mutation = S153L 
5771 57 7 1 Not sequenced 
6011 60 1 1 c-t mutation = A216V 
6121 61 2 1 g-t mutation = D236N 
6431 64 3 1 t-c mutation = Y193H 
6611 66 1 1 Not sequenced 
6841 68 4 1 Not sequenced 
7371 73 7 1 g-a mutation = G307R 
7511 75 1 1 Not sequenced 
8461 84 6 1 a deletion at nucleotide 131 = early stop codon at 
amino acid 37 
8551 85 5 1 t-c mutation = L26P 
8911 89 1 1 a deletion at nucleotide 131= early stop codon at 
amino acid 37 
9271 92 7 1 g-a mutation = G346E 
9522 95 2 2 Not sequenced 
10071 100 7 1 t-c mutation = Y180H 
10271 102 7 1 Not sequenced 
10462 104 6 2 No mutation in gene 
10831 108 3 1 Not sequenced 
11261 112 6 1 a-g mutation = Y18C 
11511 115 1 1 Not sequenced 
1Mutagenesis, plate, and isolate terms are as defined in Table 4. 
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CHAPTER FOUR 
 
DISCUSSION 
 
 The work discussed herein investigated the role of SypQ in the production of syp 
polysaccharide in V. fischeri. Site-directed and random mutagenesis identified amino acids that 
are critical for the function of the protein as well as the presence of likely conserved motifs that 
suggest SypQ functions in a GT-2-like fashion. These results contribute to a clearer 
understanding SypQ’s contribution to the formation of biofilm by V. fischeri. 
Bioinformatics Analysis  
 Bioinformatics suggests that SypQ is likely a GT-2 glycosyltransferase. Not only does 
SypQ possess a possible DxD motif, characteristic of this enzyme family, but it is predicted to 
have a large amount of structural similarity to the well-characterized GT-2 protein BcsA. 
Furthermore, because GT-2 proteins are inner membrane proteins and because two prediction 
programs indicated the presence of transmembrane segments, I hypothesize that SypQ likely 
functions from a location in the inner membrane of V. fischeri.  
The topology of SypQ remains unclear. Two separate bioinformatics programs (Topcons 
and Predictprotein) suggested that SypQ has four or five transmembrane regions, respectively. 
Topological mapping assays could be utilized to address the discrepancy [81]. SypQ’s 
orientation in the membrane could be determined with a phoA and lacZ reporters inserted into 
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the protein. Because β-galactosidase and PhoA are active only in the cytoplasm and periplasm 
[74], respectively , the positions of the active fusions would indicate the topology of SypQ. This 
information would provide insight into where the active site of the enzyme is positioned. 
Lack of SypQ Visualization 
 Visualizing SypQ will provide insight into protein levels and whether these levels 
correlate to altered biofilm phenotypes. To facilitate this visualization, I inserted a FLAG epitope 
tag at four different internal locations within SypQ, generating four individual constructs. I found 
that SypQ is permissive to the insertion of a FLAG epitope tag immediately following amino 
acid residue 36. The resulting protein is functional and able to restore biofilm to a sypQ deficient 
strain.  The other three constructs had resulted in either a diminished phenotype (aa 123) or a null 
phenotype (aa 223 and 292). There are many possible reasons for the defective phenotypes. 
Some of these possibilities include the inserted tag separating the essential aspartates, changing 
the conformation of the protein, inhibiting protein-substrate interactions, or protein degradation. 
One way to determine if the SypQ is made is by performing a co-expression assay (in strain 
KV4883).  
 Unfortunately, the protein carrying the epitope tag after residue 36 remained undetectable 
via Western blot after several attempts. This could be due to the protein being completely 
embedded in the membrane, thus occluding the epitope and making it inaccessible to the 
antibody. Isolating the inner membrane fraction via ultracentrifugation could concentrate the 
protein enough for optimal visualization via Western blot analysis. Alternatively, SypQ could be 
visualized by generating and using SypQ-specific antibody. 
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SypQ Mutagenesis  
The goal of this work was to develop a deeper understanding of SypQ function by 
performing a structure-function analysis. Through site-directed and random mutagenesis, I 
identified a large number of residues that are critical for the function of the protein. The locations 
of all generated amino acid substitutions are depicted in Figure 23. 
 
Figure 24. Depiction of generated amino acid substitutions in SypQ. The sypQ gene is depicted as a blue bar. 
The green and yellow vertical bars represent the predicted transmembrane regions and functional motifs, 
respectively. Mutations resulting in null phenotypes are depicted in red above the gene while substitutions resulting 
in delayed, diminished, and no phenotypes are indicated below the gene in green, blue and black, respectively. The 
residue predicted to be the essential aspartic acid in the DDx motif is identified by bold purple type.                                                                                           
                                                       
                                
Mutations to four SypQ residues stood out as the particularly interesting. Substitutions to 
D82, D151, S153, and D236 resulted in a severe biofilm defect. Additionally, three of the 
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residues (D151, S153, and D236) are positioned in regions corresponding to known conserved 
motifs in BcsA (DxD and TED). Another compelling factor is the high level of conservation of 
the specific residues (D82, D151, and D236) to those found in BcscA. Finally, the available data 
are consistent with the conclusion that these mutant proteins are made: I see a delay in the onset 
of biofilm when the mutated plasmids were introduced to a V. fischeri carrying a wild-type SypQ 
allele in the chromosome. The requirement for these conserved motifs strengthens my conclusion 
that SypQ is likely a GT-2.  
In addition to these four substitutions, 12 more occurred in putative non-membrane 
regions of SypQ. The four mutations that I found most interesting were either tyrosine to 
histidine substitutions or histidine to tyrosine substitutions [H214Y (occurring in two 
independent mutants), Y193H, and Y180H). Histidine residues can participate in many 
interactions, including those with divalent cations [82]. If SypQ is a GT-2 and utilizes a 
mechanism like BcsA, it could require divalent cations to stabilize the nucleotide diphosphate of 
the sugar donor. These histidine substitutions may interfere with the divalent cation’s ability to 
stabilize the donor sugar resulting in a null phenotype. The loss of histidine could conversely 
lead to a loss of cation interaction.  
The random mutagenesis also generated substitutions in putative transmembrane regions. 
Eleven of the amino acid changes occurred in predicted transmembrane regions or directly 
adjacent to predicted transmembrane regions. These mutations included proline substitutions, 
lysine to glutamic acid substitutions, and, in one case, the loss of a large side chain. Proline has a 
cyclic structure, making it rigid relative to other amino acids. While prolines naturally occur in 
membrane proteins, evidence suggests that proline substitutions are poorly tolerated by 
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membrane proteins [83]. Thus, I hypothesize that the proline substitutions introduced structural 
changes that either destabilized the protein or cascaded to the active site, affecting function. K to 
E substitutions alter the charge from positive to negative, which could disrupt specific 
interactions or alter the stability of the protein in the membrane by increasing its tendency to 
migrate away from the cytoplasm [84]. The W29A substitution also contributed to a severely 
diminished phenotype. This defect could be attributed to many possibilities. One possibility is 
that the substitution interfered with membrane stability by removing the large aromatic side 
chain since a phenylalanine substitution at the same residue allowed biofilm formation. 
The remaining mutants were less informative and, therefore, not as compelling. Site-
directed mutations to D99 and D100 resulted in no phenotypic change compared to wild-type 
SypQ, suggesting that they are neither essential nor located in critical motifs. 12 mutants had 
early stop codons but still permitted some biofilm (delayed or diminished phenotypes). Because 
some biofilm was produced, there must be some SypQ protein present. I hypothesize that protein 
was produced by some level of translational frameshift such as a stop codon readthrough or a +1-
ribosomal frameshift [85-87]. The least informative mutants had no amino acid substitutions 
present in the gene despite having a defective biofilm phenotype. One possible explanation is the 
presence of a mutation elsewhere in the plasmid, such as a change that decreases the copy 
number of the plasmid, resulting in less protein being made. 
Model for SypQ Function 
From all my data combined, I conclude that SypQ is a GT-2 enzyme that contains DDx, 
DxD, and TED motifs and that residues within these motifs play specific roles in the catalytic 
action of the enzyme (Figure 25A). The D151 and D236 residues are essential to the function of 
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SypQ and correspond to the second and third aspartic acids in the D, D, D, Q/LxxRW motif (as 
discussed in chapter one), respectively. The DxD motif has been shown to be essential to BcsA 
function by coordinating a divalent cation needed for activity [13, 16]. I hypothesize that the 
corresponding motif in SypQ, DVS, functions in a similar manner. I have depicted in Figure 25C 
how these residues, although not fully conserved, could function like the DxD residues in BcsA 
(Figure 25C). The TED motif has been shown to be responsible for deprotonation of the non-
reducing end of the growing polysaccharide chain [16]. I, therefore, hypothesize that the 
corresponding motif in SypQ, NDD, functions in a similar manner. I have depicted in Figure 
25D how these residues, particularly D236, could function like the TED motif in BcsA (Figure 
25D). If SypQ is a family 2 GT, as I hypothesize, then another aspartic acid residue, positioned 
upstream of the DxD motif, will also prove essential for the function of the enzyme. The D95 
residue in SypQ may serve that essential function: it corresponds to the conserved aspartate in 
the DDx motif of BcsA and may interact with the nucleotide diphosphate of the donor sugar 
molecule (Figure 25B). If amino acid substitutions to this residue result in a loss of function, then 
it would further suggest SypQ functions as a GT-2. I did not initially focus on the D95 residue, 
as the other aspartate flanking it in the DDx motif of BcsA is not conserved. However, given the 
conservation of the aspartate residue in SypQ relative to BcsA, its position relative to the other 
functional motifs, and the known requirements for the three sets of aspartate residues, I now 
conclude that D95 warrants further investigation. Finally, I further hypothesize that a motif with 
a function analogous to that of the Q/LxxRW motif is present in SypQ. Residues in the 
Q/LxxRW motif interact with the donor sugar molecule and the growing polysaccharide chain 
[88]. SypQ does not have a true Q/LxxRW motif at the same location as BcsA, AcsA, or NodC. 
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However, it does have two highly conserved arginine residues (R273 and R275) present at the 
location of the known Q/LxxRW motif. I hypothesize that the R275 residue is likely interacting 
with the nucleotide diphosphate of the donor sugar (Figure 25E) and should be targeted for 
future mutagenesis.  
Using the Phyre 2 software, I highlighted all of the amino acid residues whose 
substitution resulted in null phenotypes as well as D95 and R275 on a 3-dimensional ribbon 
diagram of SypQ (Figure 26). The residues predicted to be in GT-2 motifs appear to be centered 
in or around the predicted active site supporting my hypothesis that SypQ is a family 2 
glycosyltransferase. I then utilized the Phyre 2 software to identify more residues to target for 
mutagenesis (Figure 27). The Phyre 2 investigator tool provides amino acid preference and 
mutational sensitivity predictions for each residue in SypQ. Using this software, I identified 
residues that had high mutational sensitivity profiles as targets for future mutagenesis. The 
targeted amino acids are listed in Table 7. Mutagenesis to these residues can further our 
understanding of how SypQ contributes to the formation of syp polysaccharide in V. fischeri. 
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Figure 25. Predicted model of active site mechanism and role of identified residues. A. A depiction of the role 
of the GT-2 motifs in SypQ. Predicted hydrogen bonding interactions are indicated by red dashed lines, the 
movement of electrons are indicated by blue arrows, and predicted van der Waals forces are indicated by the purple 
dashed lines. The corresponding residues in SypQ are in parentheses. B. Predicted contribution of the D95 residue in 
SypQ. C. The predicted role of the D151 and S153 residues in SypQ. The divalent cation is represented by the 
orange square. D. The predicted mechanism of action of residue D236 in SypQ. E. Predicted role of R275 in SypQ 
and the know function of the tryptophan residue in the Q/LxxRW motif in processive GT-2s. These predictions are 
based on interactions known to occur in the GT-2 enzyme BcsA [13, 15, 16]. 
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Figure 26. Model depicting locations of residues contributing to null phenotypes. The blue ribbon diagram 
indicates the SypQ structure as predicted by the Phyre 2 software. Residues located in predicted transmembrane 
regions are colored cyan. Residues predicted to be in the DxD and TED motifs are colored yellow. Residues that are 
neither in motifs or transmembrane regions are colored red. The white residue indicates the location of R275 while 
the green residue indicates the location of D95 [71].  
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Figure 27. Mutational sensitivity profile predicted by the Phyre 2 software for SypQ residue D151. The profile 
for D151 is depicted as an example of high mutational sensitivity. The sequence profile predicts the residue 
preference at each location. High and red bars indicate high preference while low and blue bars indicate low 
preference. The mutation profile indicates the sensitivity of the residue at that location to substitutions by different 
amino acids. High and red bars indicate a high sensitivity to mutation while lower blue bars indicate less sensitivity 
[71]. 
 
Table 7. Residue predictions and suggested mutations.  
Residue in SypQ Predicted role Expected phenotype 
   
P56 Structural contribution P56A = null 
I58 Unclear – located in β sheet 
in putative active site 
I58D = null 
I61 Unclear – located in β sheet 
in putative active site 
I61A = null 
I62 Unclear – located in β sheet 
in putative active site 
I62D = null 
P63 Structural contribution P63A = null 
A64 Unclear – located in β sheet 
in putative active site 
A64D =null 
I71 Unclear – located in α helix 
near putative active site 
I71D = null 
I90 Unclear – located in β sheet 
in putative active site 
I90D = null 
D95 Interaction with the D95A/D95E = null 
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nucleotide diphosphate of the 
donor sugar 
phenotype 
S153 Coordination of divalent 
cations 
S153A/S153E = null 
phenotype 
R273 Stabilization of the 
penultimate sugar in the 
polysaccharide chain 
R273K =diminished 
phenotype 
R273A = null phenotype 
R275 Stabilization of the 
penultimate sugar in the 
polysaccharide chain 
R273K =diminished 
phenotype 
R275A = null phenotype 
 
SypQ is not likely to act alone in synthesizing the Syp polysaccharide. As discussed in 
appendix A, the other five Syp GTs (SypH, I, J, N, and P) encode putative family 1 
glycosyltransferases (GT-1) that, I predict, generate the activated sugars necessary to produce 
Syp polysaccharide.  I propose that SypQ functions in conjunction with the other Syp structural 
proteins (SypC, SypD, SypK, SypL, and SypO) to polymerize the individual sugars supplied by 
the five GT-1 proteins into a larger polysaccharide chain that gets modified and exported out of 
the cell. I further hypothesize that SypQ is likely functioning as a polymerase in a Wzx/Wzy-
dependent pathway. In support of this proposal, specific Syp structural proteins (SypC, SypK, 
SypL, and SypO) have sequence homology to Wzx/Wzy-dependent proteins (Wza, Wzx, WaaL, 
and Wzz, respectively) [7, 8]. If these proteins do indeed function like other Wzx/Wzy-based 
systems, then it is likely that SypQ polymerizes a polysaccharide in the cytoplasm that is 
transferred to the periplasm via the putative flippase SypK. As discussed in chapter one, the 
polysaccharides produced by the Wzx-Wzy pathway are almost exclusively heteropolymers. 
Given the predicted function of SypQ as a GT-2 family protein, the presence of Wzx/Wzy-like 
Syp structural proteins, and the presence of multiple GT-1 family proteins each predicted to yield 
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activated sugars, I conclude that the polysaccharide produced by SypQ is most likely a 
heteropolymer.  
This conclusion, however, contradicts that of a recent study that investigated the role of 
SypQ in Vibrio parahaemolyticus [89]. Ye et. al. determined that sypQ is critical for biofilm 
formation, as I and others have demonstrated to be the case in V. fischeri [7, 52]. The V. 
parahaemolyticus study concluded that SypQ facilitates the formation of the homopolymer 
PNAG (poly-N-acetyl glucosamine) and functions in a PgaC-like manner. In E. coli, PgaC is part 
of a synthase-dependent EPS biosynthesis pathway rather than a Wzx/Wzy-dependent pathway 
[22, 90]. Thus, this conclusion suggests that SypQ is polymerizing and translocating the 
polysaccharide, PNAG, simultaneously. This pathway of homopolymer polysaccharide 
production seems unlikely, given that (1) GT-2s functioning within Wzx/Wzy-dependent 
pathways produce heteropolymers and (2) the syp locus in V. parahaemolyticus is largely 
conserved relative to the V. fischeri locus and also encodes Wzx/Wzy-like structural proteins as 
well as GT-1 family proteins [52]. These conclusions, along with the data I have presented in this 
thesis, highlight the need for further investigation into the specific function of SypQ in 
polysaccharide production.  
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 To better understand the syp polysaccharide and how SypQ contributes to it, I used 
bioinformatics to look more closely at the other five syp glycosyltransferases: H, I, J, N, and P. I 
submitted the amino acid sequences for the GTs to the Phyre program to elucidate potential 
structures for these proteins.   
 GTs H, I, J, and N all had the same predicted structure. They all were matched to the 
structure for the apo sucrose phosphate synthase (SPS) (Figure A1). The SPS protein is a family 
1 glycosyltransferase that consists of a GT-B fold consisting of two β/α/β domains that face each 
other to form a cleft in which lies the active site (Figure A2). In addition to the GT-B structural 
fold, the family 1 glycosyltransferases utilize a retaining mechanism of action.  
 
 
Figure A1. Phyre results for Syp glycosyltansferases H, I, J, N, and P. The top results from the Phyre 2 software 
show the confidence number in the red box. The percent identity of the query sequence that aligns with the resulting 
sequence is in the second box. The protein to which the query sequence was aligned is in the box titled template 
information. Boxed on the left are the percentage of the query sequence that aligned with the structure of the 
resulting protein [71]. 
94 
 
 
 
 
 
 
Figure A2. Structure predicted for Syp glycosyltransferases H, I, J, and N by Phyre. The predicted 
alpha helices are depicted in pink while predicted beta sheets are depicted in yellow. The N-terminal end of the 
protein is indicated by the blue arrow and the C-terminal end is indicated by the green arrow [71]. 
 
 The SPS enzyme is responsible for the first step in the synthesis of sucrose: transferring a glucose 
molecule to fructose-6-phosphate to make sucrose-6-phosphate [91]. After this step, a sucrose 
phosphatase (SPP) protein removes the phosphate resulting in sucrose.  
 The SypP protein sequence matched to a different structure: MshA (Figure A1 and A3). The 
MshA protein is a member of the family 4 glycosyltransferases (GT-4) which, like the GT-1s, utilize a 
retaining mechanism of action. MshA also has a GT-B structural fold.  
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Figure A3. Predicted structure for SypP by Phyre. The predicted alpha helices are depicted in pink while 
predicted beta sheets are depicted in yellow. The N-terminal end of the protein is indicated by the blue arrow and the 
C-terminal end is indicated by the green arrow [71]. 
 
 The MshA enzyme catalyzes the first step in mycothiol biosynthesis [92]. This enzyme produces 
GlcNAc-Ins using UDP-GlcNAc as a donor and 1L-Ins-1-P as an acceptor. This molecule will then 
undergo four more reactions to eventually become mycothiol. Mycothiol is a thiol commonly produced 
and used by mycobacteria. 
 While these data give some insight into the possible contribution of these five Syp GTs to the 
production of the syp polysaccharide, it still leaves many questions unanswered. What do these Gts 
produce? What are their substrates? What is the significance that the SypP structure is predicted to differ 
from the other Syp GTs? I hypothesize that these GTs are responsible for producing individual sugars that 
are then polymerized into a longer polysaccharide chain by SypQ. 
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